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ABSTRACT 
Lymph node (LN) blood supply has long been thought to be integral to the 
immune response. Recently, the phenomenon of remodeling of the LN feed arteriole 
during viral infection was demonstrated as a key component of induction of an effective 
adaptive immune response. Here, the data presented show that during infection the LN 
feed arteriole is capable of non-pathogenic, reversible, outward remodeling peaking 
seven days post-immunization before returning to pre-infection size. Using 
pharmacological blockade and genetic ablation models, the remodeling process is 
demonstrated to be dependent upon the presence of CD4+ T cells in the LN, the 
expression of endothelial nitric oxide synthase (eNOS), tumor necrosis factor alpha, and 
age, as well as influenced by mast cells. Collectively, these results demonstrate key links 
between immune response, arteriole remodeling, and vascular mediators and represent a 
novel mechanism of vascular modulation of immunity. 
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CHAPTER ONE - GENERAL INTRODUCTION 
1.1 Microvascular and Arteriolar Physiology 
General Physiology 
The microvasculature running throughout the body is a complex, vital network 
composed of arterioles, capillaries and venules. Traditionally, people associate 
microcirculation with the exchange of oxygen, nutrients, waste products, and hormones 
in vascular beds throughout the body, and generally, vessels less than one hundred 
micrometers in diameter are considered to be part of the microcirculation. A branch of a 
larger artery, arterioles consist of endothelial cells lining the lumen of the vessel 
(endothelium) and smooth muscle layer(s) wrapping around the vessel. The chief 
function of an arteriole is to maintain resistance within the microvascular network. 
Regulation of blood flow through arterioles occurs via vasoconstriction and vasodilation, 
which result from signals acting on the endothelium and smooth muscle cells (SMCs) as 
well as nervous system innervation. In a majority of tissues, arterioles are enervated by 
the sympathetic nervous system that influences vascular tone through nerve fibers. 
Postganglionic never fibers release norepinephrine, which predominately binds to alpha 
adrenergic receptors on SMCs and activates the phosphatidylinositol bisphosphatc second 
messenger system leading to SMC constriction. The degree of constriction, or 
maintenance of homeostatic vascular tone, is determined by the level of norepinephrine. 
Alternatively, epinephrine, secreted from the adrenal medulla, has the ability to bind both 
alpha and beta-2 adrenergic SMC receptors, where beta-receptor activation leads to 
vasodilation through the production of cyclic adenosine monophosphate (AMP) 
(Germann & Stanfield, 2005). In general, this means that the degree of SMC activation, 
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and therefore the relative degree of vasoconstriction or dilation, is the vascular state 
required to maintain normal function and is a vessel's "set-point" under normal 
physiological conditions. 
Vascular tone is a large factor in arteriolar networks, which arise from an initial 
branch from an artery. This primary branch is termed A] and ranges from 80 tol40um. 
Subsequent arterioles branching from the Ai arteriole are termed A? (40 - 80iim) and A3 
(20 - 80j.im) with arteriolar networks terminating into capillaries beds (Crijns et ai, 
1998). Capillaries primarily function in allowing exchange between blood and tissues 
throughout the body. This task is facilitated by the highly branched nature of capillary 
networks that provides a large surface area that abets diffusion. Diffusion is also aided by 
the make-up of the capillary as the single layer of endothelial cells comprising capillaries 
makes rapid exchange with the target tissue possible. Following tissue perfusion, 
capillary beds collect into venular networks, which allow return of blood from capillary 
beds to venous circulation and return of blood supply to the heart (Grecnberger, 1998). 
Through the complete cycle, from heart to capillary bed and back, normal vascular 
function is required to maintain physiological homeostasis. Accordingly, vasculature will 
react dynamically, either through short or long-term responses to preserve functions 
within normal limits. To meet tissue demands in the short term, tissue perfusion is 
regulated by changes in vessel diameter by altering levels of smooth muscle cell (SMC) 
activation. Dilation is achieved via signaling within the SMC and ECs to induce a state of 
SMC relaxation and subsequent hyperemia. In addition to enervation, there are three 
main mechanism which facilitate SMC relaxation: nitric oxide (NO), endothelium-
dcrived hypcrpolarizing factor (EDHF), and protaglandin I2 (PGl: or prostacyclin). When 
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produced in ECs of the arteriole, NO, EDHF, and PGI? lead to production of cyclic 
guanosine monophosphate (cGMP), opening of potassium channels with subsequent 
hypcrpolarization of the SMC, and increased cyclic AMP respectively. Regardless of the 
upstream mechanism, all three induce a decrease in calcium ions in the SMC leading to 
vasodilation. Release of NO, PGI;?, and EDHF from the EC is triggered by an influx of 
calcium into the EC, with increasing intercellular calcium being a function of stimulation 
of receptors on the surface of the EC (Vanhoutte, 2003). Though many factors can 
activate ECs, a notable factor in EC activation within a study concerning changes in 
blood flow is shear stress. Blood flow within an arteriole generates shear stress on the 
vessel wall and changes in blood flow velocity will alter shear stress levels as it is 
proportional to the force applied to the vessel wall by the fluid moving through it and 
inversely proportional to the diameter. Therefore, increased shear stress causing EC 
activation and vasodilation acts to return shear stress to homcostatic levels. (Koller & 
Kaley, 1990, Koller Kaley, 1989). Vascular response to shear stress is achieved through 
mechano-sensors that include integrins such as av^3 and Pi, ion channels including those 
of calcium and potassium, G-proteins such as Ras, and receptor tyrosine kinases like Flk-
1. Sensed changes in shear stress can result in a number of different physiological 
outcomes including EC proliferation, apopotosis, migration, and permeability (Li et at., 
2005). 
Microvascular A Captation 
Changes in SMC activation state leading to vasodilation and vasoconstriction arc 
primarily a short-term response, but to meet physiological demands in the long-term, 
vascular changes often take the form of structural adaptation or remodelling, in which 
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any or all of diameter, wall thickness, wall cross-sectional area, and wall to lumen ratio 
can be affected (Mulvany, 1999). Oxygen levels, cytokines, and metabolic demands can 
direct structural adaptation, but the largest factor directing adaptation is hemodynamics; 
blood flow is responsible for inducing shear stress on the vessel wall, while changes in 
transmural pressure result in alteration of circumferential wall tension (Pries & Secomb, 
2002). Structural changes arc categorized as hypotrophic, cutrophic, or hypertrophic. 
From their original state, vessels that exhibit no change in wall cross-sectional area arc 
termed cutrophic, while those that show increased or decreased wall cross-sectional area 
are termed hypertrophic or hypotrophic respectively. An increase or decrease in cross-
sectional area indicates a change in the amount of material within the wall (Mulvany, 
1999), and changes in wall material can be the result of a number of mechanisms 
including EC proliferation, EC recruitment, mural cell recruitment, EC hypertrophy, or 
EC apoptosis (Dajnowiec & Langille, 2007, Li et al., 2005, Yu et al., 2005). These three 
forms of remodeling, eu-, hyper-, and hypo-trophic, can be further categorized as inward 
or outward remodelling. Inward remodelling refers to a decrease in lumen diameter, 
while an increase is termed outward remodelling (Mulvany, 1999). 
In addition to structural adaptation, vascular changes can also take the form of 
increasing or decreasing blood vessel numbers or recruitment. Angiogcnesis is the 
formation of new blood vessels. During angiogcnesis, a number of factors act on ECs 
including fibroblast growth factor, angiopoietin-land vascular endothelial growth factor 
(VEGF) (Ferrara et al, 2003, Ferrara et al, 1992, Leung et al, 1989). Of these factors, 
VEGF is one of the most potent and critical growth factors implicated in arteriogencsis, 
increased diameter of existing arterioles or recruitment and expansion of collaterals, 
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vasculogenesis, de novo formation of blood vessels, EC division in stimulated LNs, and 
lymphangiogensis, formation of an increased lymph network (Fcrrara et al., 2003, Hcil 
et al., 2006, Nagy et al, 2002, Webster et al., 2006). Within the vasculature, VEGF is 
responsible for regulating EC proliferation, sprouting, migration, and survival as well as 
influencing vascular permeability mediated via interface with EC through binding to 
VEGF receptors 1 and 2 (VEGFR1, VEGFR2) on the EC surface. Ligand binding to the 
VEGF receptor induces oligomerization and activation through phosphorylation of 
residues within the oligomer. This then induces recruitment of intercellular signaling 
molecules to interface with the receptor complex and numerous down stream effects 
including factors that will be important considerations in this project such as changes in 
nitric oxide synthase activity, EC permeability, and EC proliferation (Stuttfeld & 
Ballmer-Hofer, 2009). The signaling cascade downstream of VEGF receptor activation is 
extensive. Generally however, interface with PLC-gamma leads to regulation of 
endothelial nitric oxide synthase and EC permeability. Meanwhile, activation of RAS, 
cSrc, and PI3K set off a signaling cascades that promote EC proliferation, EC migration 
and inhibition of apoptosis respectively (Ferrara et al., 2003, Nieves et al, 2009). 
Nitric Oxide 
As cvidenccd above, vascular mediators are integral components of vascular 
function. One such mediator, which will prove to be integral to this project, is NO, an 
endothelium-dependent vasodilatory agonist. Constitutive NO within the vasculature is 
produced by endothelial nitric oxide synthase (eNOS), which produces NO through 
catalyzing the conversion of L-argininc to L-citrulline. However, other isoforms of NOS, 
namely neuronal NOS and inducible NOS, produce NO through the same conversion 
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(Scssa, 2004). Within the microvasculature, NO is noted to play key roles in regulating 
vasodilation, anti-coagulation, inflammation, vascular remodeling, and angiogencsis 
(Sessa, 2009). 
NO induced vasodilation results from diffusion of NO from the endothelium to 
SMCs causing relaxation. This is primarily mediated through activation of guanylatc 
cyclase, which in turn catalyzes the production of cyclic GMP from guanosinc 
triphosphate (GTP). cGMP production activates potassium channels leading to SMC 
hyperpolarization and therefore, induction of a relaxed state (Vanhoutte, 2003). In 
addition to diffusion to act on SMCs, NO also diffuses into the lumen of blood vessels 
where it exhibits its anti-coagulation effccts stemming from its ability to prevent platelet 
adherence and promote segregation of amassed platelets as evidence by decreased 
bleeding times and increased platelet adhesion in eNOS deficient mice (Frecdman, 1999, 
Scssa, 2009, Vanhoutte, 2003). Beyond preventing the adhesion of platelets, NO also 
inhibits inflammatory cell adhesion, which will be detailed further in subsequent chapters 
in consideration of cellular trafficking cascades (Akimitsu et al., 1995, Kubes, 1991, 
Martinelli et al., 2009). Increased vascular leakage during inflammation is thought to be 
the result of NO, as genetic ablation of eNOS demonstrate decreased vascular leak. This 
inhibition is maintained with blockadc of PI3K and Hsp90, positive regulators of NOS 
activity, or increased levels of caveolin, a negative regulator of NOS activity (Bucci et 
al., 2005, Hatakcyama et al., 2006). NO is also a key factor in the regulation of vascular 
changes induccd by VEGF as mice deficient in eNOS lack the ability to respond to 
VEGF. Additionally, in ischemic conditions, loss of eNOS results in reduction in 
angiogencsis, arteriogencsis, and mural ccll recruitment (Yu et al., 2005). This may be 
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the result of the requirement of NO to stimulate endothelial cell proliferation in response 
to shear stress generated by high flow (Metaxa et ai, 2008). Alternatively, cNOS may be 
regulating VEGF levels as exogenous delivery of cNOS has been shown to increase 
VEGF expression and give rise to mature phenotype in newly formed arterioles and 
capillaries (Benest et ai, 2008). Collectively, these studies demonstrate the diverse role 
of NO in the vasculature and in facilitating changes in vascular physiology to meet 
physiological demand. Furthermore, the varied impact of NO on immune regulation will 
subsequently be presented, and when the roles of NO in the immune response and in 
vasculature arc combined, supports investigation of NO in the LN and are detailed in 
Chapter 5. 
1.2 Lymph Node Physiology 
Lymph Node Function and Architecture 
LNs are distributed throughout the body, ranging from cervical, to mesenteric, to 
inguinal, and popliteal. Generally, LNs are secondary lymphoid organs with the chief 
function of collecting antigen (Ag) and antigen presenting cells (APCs) from the 
periphery that present antigen to naive lymphocytes that traffick to the LNs, thereby 
making LNs an intense site of immune activity (Murphy et ai, 2008). LNs serve as an 
interface between the innate and adaptive immune system. Pathogen associated molecular 
patterns (PAMPS) of infiltrating pathogens arc sensed by a host and taken up by APCs in 
the periphery at the site of infection. While a variety to cells can be APCs, such as 
macrophages, ECs, and B-cells, they are most commonly dendritic cells (DCs), which are 
termed professional APCs. A variety of DCs exist; DC subsets are defined by their 
surface antigens, and differ based on tissue localization and mechanisms of capturing and 
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processing antigen. The main class of DCs that is associated with LNs is the conventional 
DCs (cDCs) class. Migratory cDCs exist in an immature state in the periphery and 
subsequently mature and migrate through the lymph into the draining LN and present 
antigen on major histocompatibility complex (MHC) molecules following internalization 
of antigen. Alternatively, free antigen can be transported to the lymph node and 
processed and presented in the LN by resident or blood-derived cDCs (Randolph et al, 
2005, Villadangos & Schnorrer, 2007, Murphy et al, 2008). 
Once antigen is presented, the search for rare cognate T cells begins. Given the vast 
diversity of T-cell receptors, only one in 10s to 106 cells in a mouse are specific for a 
given antigen, the rapidity of this process is vital to quick on-set of adaptive immune 
response (Casrouge et al., 2000). Screening of naive T cells within the LN is dependent 
upon T cells numbers, blood supply to the LN, density of DCs within the node, and 
antigen dose. If a naive T cells is cognate, it will remain in the lymph node and undergo 
clonal expansion, but most cells entering the LN are not cognate and return to the 
circulation though efferent lymph vessels. Successful DC interaction with a cognate naive 
T cell occurs in three phases and is dependent on cytokine expression and co-stimulatory 
molecules (Henrickson, 2008, Sodcrbcrg, 2005). Following clonal expansion, 
lymphocytes acquire cffcctor cell functions, which are antigen specific, thereby inducing 
an adaptive response specific to the invading pathogen, and are critical for fighting 
infection. The process of amassing nai ve T cells within the LN during the on-set of 
adaptive immunity results in LN hypertrophy, however, this state of increased ccllularity 
and swelling resolves (Murphy et al., 2008, Soderberg et al, 2005). 
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Whether in a state of hypertrophy or not, the internal structure of the LN is 
distinctly organized with two main divisions: the cortex and the medulla. The cortex is 
segmented into a paracortex or T cell area surrounded by a B-cell area in the outer cortcx. 
The T cell area is the main site of screening for cognate T cells and subsequent activation 
and proliferation. The B-cell area is comprised of primary follicles and germinal centers 
where activated B cells proliferate and differentiate. The medulla is made up of sinuses 
that drain the lymph and arc separated by medullary cords. While a variety of cells have 
been noted to reside in medullary cords, such as plasma cells and macrophages, the role 
of the medulla is yet to be clearly understood (von Andrian, 2003). 
Lymph Vascularization 
The microvasculature interacts with and influences the immune system in a variety 
of ways from expression of regulatory cytokines, to cell trafficking, impact of flow 
dynamics, and supply of metabolites. Therefore, continuing to elucidate the interface 
between the immune and microvasculature systems is important and LNs are an excellent 
choice for exploring such immune-microvascular interaction, as they are highly 
vascularized and key for rapid induction of host-defense mechanisms. In addition to 
having a highly complicated internal structure, lymph nodes also have a well-defined and 
complex vasculature. The vasculature of the LN can be divided into a number of pieces 
with the main feed arteriole being the upstream supplier of blood. This arteriole branches 
into a capillary network and then into specialized post-capillary venules that feed the LN. 
These post-capillary venules are known as high endothelial venules (HEVs). HEVs 
consist of a single layer of cuboidal endothelial cells specialized to facilitate movement 
of cells into the LN. HEVs occur at in the centre of paracortical cords and occur most 
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frequently in T-cell zones to optimize delivery of blood borne lymphocytes during 
homeostatic immune surveillance and induction of adaptive response. HEVs are 
surrounded by layers of fibroblastic reticular cells (FRCs), and unlike normal venules, 
they have a thick basal lamina and notable perivascular sheath (von Andrian & Mcmpel, 
2003, Murphy et al., 2008, Miyasaka & Tanaka, 2004). The endothelium of HEVs is 
critical to successful lymphocyte migration into the LN (Marchcsi & Gowans, 1964) and 
extensive research regarding signaling molccules and chcmokinc expression patterns in 
HEVs, which enable cell trafficking both in the presence and absence of infection, have 
been conducted and are discussed below. 
Lymph Node Trafficking 
The general trafficking cascade in all tissues involves rolling, activation, adhesion, 
and transmigration. Within peripheral LNs, rolling is mediated by the expression of 
highly glycosylated and sulphated sialomucins known as peripheral node addressins 
(PNAds) on the HEV. Lymphocytes targeted to LNs express L-selectin, which bind to 
PNAd (Ley et al., 2007, Miyasaka & Tanaka, 2004). Notably, the expression of PNAd is 
itself regulated as PNAd levels have recently been shown to be controlled by expression 
of lymphotoxin-p receptor (LTpR), with blockade of LTpR leading to decreased 
cellularity in reactive lymph nodes (Browning et al., 2005). Following rolling, activation 
involves the interaction of CC-chemokine receptor 7 (CCR7) with CC-chemokinc ligand 
21 (CCL21) and CCL19 as well as the interaction of CXC12 with CXCR4. This type of 
interaction, chcmokinc binding to a chemokine receptor initiates intercellular signaling 
via the Gicx pathway, which leads to conformation changes that allow adhesion or arrest 
to be achieved. In the LN, this occurs by leukocyte function-associatcd antigen (LFA-1) 
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binding to intercellular adhesion molecules (ICAMs). Importantly, it is this trafficking 
cascade that allows selective recruitment to the LN. For example, L-selectin is not 
expressed in effector memory T cells therefore they fail to roll along the endothelium and 
do not migrate into the LN and while myeloid cells can roll as they typically express L-
selcctin, they fail to arrest to the absence of CCR7 or CXCR4 (Ley et al., 2007, Miyasaka 
& Tanaka, 2004, von Andrian & Mempel, 2003). L-selectin expression is particularly 
important in terms of CD41 T cell trafficking to draining lymph nodes during induction of 
adaptive response; L-selectin is required for naive T cell migration into LN as systemic 
treatment with antibody against L-selectin prevents accumulation of naive CD4f T cells 
(Bradley et al., 1994). 
Blood flow is also a factor to consider within the lymphocyte trafficking cascade as 
leukocytes within the blood flow at a rate of l-10mm/s, which is too fast for migration 
and therefore dictates the need for selcctin mediated adhesiveness along the vessel wall. 
Interaction with the vessel wall is also impacted by blood flow, as it is known to 
influence the arrangement of leukocytes within vessels as well as regulate cellular rolling 
speed along the endothelium; in states of high flow and shear rate, leukocytes are 
buffered away from the vascular endothelium and have a rolling speed too high for 
optimal trafficking (Kubes et al., 1991, Ridgcr et al., 2008). Conversely, the absence of 
flow has been shown to cause rolling lymphocytes to disengage from the endothelium, a 
phenomenon known as the 'shear threshold effect'. This phenomenon refers to the 
maximal binding of L-selectin to PNAd at ldyn/cm2, and drops significantly below 
0.6dyn/cm2. This effect is largely specific to L-selectin, but is worth serious consideration 
as L-selectin is a key mediator of naive T cell trafficking into peripheral lymph nodes. 
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(Finger et ai, 1996). Shear stress is also associated with changes in expression levels of 
adhesion molecules on the vascular endothelium as well as the stability of interaction 
between such adhesion molecules and integrins on the surfaces of migrating T cells. A 
LN specific example of this is lymphocyte function-associated antigen-1 (LFA-1) and 
intercellular adhesion molecule-1 (ICAM-1); the activation of LFA-1 to a low affinity 
extended state from a bent low affinity conformation is promoted through the chemokine 
CCL21. Notably, CCL21 immobilized on the endothelium is hypothesized to silence 
integrins in the absence of force generated by flow. Subsequent to the conversion to a low 
affinity extended state, the force of flow within a vessel is then also responsible for 
converting a LFA-1 to a high-affinity extended conformation, thereby allowing 
engagement of ICAM-1 and arrest on the endothelium. (Sucosky et ai, 2009, McEver & 
Zhu, 2007, Alon & Dustin, 2007). 
As previously discussed in relation to vascular function, NO is a mediating factor in 
blood flow regulation and therefore has an indirect impact on trafficking within the LN 
via altered hemodynamics. However, NO also has direct impact on trafficking. NO has 
been shown to attenuate leukocyte adhesion to endothelium. This presented targeted 
treatment with exogenous NOS inhibitors such as a possible mechanism to influence 
leukocyte adhesion, and was subsequently demonstrated by Kubes and colleges (1991) 
whom showed a 15-fold increase in leukocyte adherence in post-capillary venules 
following treatment with NOS inhibitors L-Nitro-Arginine Methyl Ester (L-NAME) and 
N-Methyl-L-argininc acetate (L-NMMA). Increased adherence was also accompanied by 
higher rates of emigration and decreased vcnular shear (Kubes, 1991, Akimitsu et ai, 
1995). Inhibition of NOS has also been shown to further increase leukocyte rolling in 
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sepsis, wherein rates of rolling and adhesion are already high, and was reversible by 
administration of L-arginine (Sundrani et al., 2000). This suggests that exogenous supply 
of L-arginine may be useful in increasing the bioavailability of NO in states of adverse 
immune reaction and could potentially be used to aid NO production and inhibit 
lymphocyte adhesion. Additionally, recent studies provide evidence that NO may also 
promote lymphocyte transmigration through stimulation from ICAM-1 (Martinelli et al., 
2009) with the ability of some leukocyte subsets to bind ICAM-1 and mediate adhesion 
demonstrated to be NO dependent (Norman et al., 2008). 
1.3 Changes in Lymph Node Vasculature & Study Objectives 
Vascularization During Immunization 
The question of how antigen stimulation causes an increase in trafficking of 
lymphocytes from the blood has been asked for decades. Studies aimed at answering this 
question have generally fallen into two categories: those looking at increased recruitment 
into the lymph node, and those looking at increased blood flow to the lymph node. The 
first, increased cellular recruitment, refers to the ability of the immune system to interact 
with lymph node microvasculature to create a microcnvironmcnt that favors movement of 
circulating lymphocytes into the lymph node thereby increasing the percentage of cells 
transmigrating into the node. As detailed above in the discussion of lymph node 
physiology and lymphocyte trafficking, this is a complex interplay of adhesion 
molecules, selectins, chemokincs, and rcccptors. The second, increased blood flow, is as 
of yet, less defined. Early studies using radiolabeled microspheres showed increased 
blood flow to draining lymph nodes which mirrored lymph node weight during immune 
response (Hay & Hobbs, 1977). Additional studies using microangiography of rabbit LNs 
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showed vascular changes beginning in the subcapsular and medullary cords within the 
first day of antigen challenge that peaked at day five. This vascular growth was 
subsequently shown to involve the LN cortex by day three, facilitating vascularization of 
the hypertrophied LN and germinal centers. Despite this vascular expansion, 
microvasculature returned to normal by day seven (Herman et ai, 1972) and the author's 
theorized that areas within the LN with increased blood flow was the result of shunting 
and vessel rearrangement, not angiogenesis. However, further study of vascularization of 
LN using LNs draining skin allografts demonstrated increased length of HEVs and HEV 
arborization (Anderson et al., 1975). 
More recent studies of LN vasculature have begun to further elucidate changes in 
LN vasculature at the HEV level. HEVs are noted to exhibit plasticity in terms of 
expression of addressins and morphology in response to changes in flow dynamics and 
gene expression (Browning etal., 2005, Hcndriks et al., 1987), with Hendriks and 
colleges reporting decreased endothelial surface area and flattening of ECs in response to 
limiting afferent lymphatic flow (Hendriks et al., 1987). But, when considering HEV 
alteration in the context of immunization, early reports note dilation of HEVs as indicated 
by increase in cross-sectional area and accompanied by increased EC size within the 
vessel (Myking, 1980). However, a number of studies support HEV proliferation over 
dilation; Mcbius and colleges (Mcbius et al., 1990) show increased HEV staining within 
the LN T cell zone during immunization, and Soderberg and colleges report that HEV do 
not increase in size, but instead increase in number proportional to lymph node size and 
cellularity during challenge with herpes simplex virus type 11 (Soderberg et al., 2005). 
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A number of mechanisms are proposed for regulating LN vasculature at the level of 
the HEV. Liao and Ruddle (2006) demonstrate HEVs and lymphatic vessels exhibit 
synchronistic plasticity and remodel during immunization through B cell and LT^R 
cross-talk. Subsequent studies demonstrated B cells to be specific to expansion of the LN 
lymph network and migration of DCs to the LN (Angell et al, 2006). Other studies later 
identified LT^R to be a regulator of fibroblast-type reticular stromal cell (FRC) 
production of VEGF in the lymph node (Chyou et al., 2008), a study based on previous 
findings that VEGF levels within the LN were responsible for vascular growth. Notably, 
VEGF is known to be expressed or induced by a variety of immune cells including B 
cclls, DCs, and T cclls (Ruddell et al., 2003, Webster et al., 2006, Zhao et al, 2004), but 
in direct study of vascular growth of HEVs, as was indicated by EC proliferation, VEGF 
expression was demonstrated to be dependent on DCs in the LN (Webster et al., 2006). 
Most interestingly perhaps, in accordance to the relation to LN cellularity and rapid 
induction of adaptive immune response, blockade of LTfiR or decrease in DC numbers 
was sufficient to decrease VEGF levels and EC proliferation within the LN, resulting in 
decreased cellular accumulation (Chyou et al, 2008, Webster et al., 2006). 
Despite the number of studies on general increase in blood flow to LN and vascular 
expansion within the LN at the HEV and lymphatic drainage levels, there is a paucity of 
information in regards to how blood flow to the LN and HEVs during immunization is 
accomplished upstream. In fact, the only study to specifically address this question 
identified the LN feed arteriole to be the key upstream regulator. This study showed that 
three days post-infection with herpes simplex type II there is significant remodeling to a 
larger arteriole diameter, which was recorded to be fifty percent larger than prior to 
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infection. Such an increase allowed increased blood flow and supply of naive T cells to 
the LN, and thereby increased the rate of screening for rare cognatc lymphocytes from 3 
x 106 cclls/day, which has been noted in a naive mouse, to 14 x 106 cells/day. Increased 
arteriole diameter was also noted to correspond with cellular accumulation and HEV 
proliferation (Soderberg et al., 2005). 
Study Objectives 
Study of changes to the LN feed arteriole by Soderberg and colleges (2005) 
effectively demonstrated the existence of an integral link between the immune system 
and microcirculation in the LN at the arteriolar level. Given the correlation between 
increase in arteriole size, lymph node cellularity, and HEV number and blood flow, the 
regulation of blood flow upstream of HEV within the LN most probably has an impact on 
downstream vasculature, and therefore, could regulate cellular trafficking and the 
induction of adaptive immune response. While suggestion of such a link is novel within 
the LN, the concept of the control of upstream events on downstream outcomes is not; 
history has shown us that understanding what is located above the direct point of interest, 
such as in signaling cascades, or perhaps more relevantly as in hyperemia to peripheral 
inflammatory sites or active muscle, can provide new insight into downstream events and 
potential therapeutics avenues, and thereby speaks to the importance of further 
understanding upstream regulation of LN vascularization. Therefore, in an effort to 
understand and explore therapeutic applications of changes in arteriolar vascularization of 
the LN during immune response, this project aims to study the LN feed arteriole in order 
to address many important and as of yet unanswered questions that must be addressed. To 
this end, the main objectives of this study arc: 
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(i) To clucidatc the extent and nature of vascular remodeling within draining 
lymph nodes during infection upstream of HEVs at the arteriolar level and 
consider the potential impact of such remodeling on health and disease. 
(ii) Begin to elucidate the mechanism of draining lymph node vascular 
remodeling in order to identify future targets for control of LN vascular 
supply. 
In meeting these objectives, the hypothesis that arteriole remodeling is a 
phenomenon driven by vascular and immune mediators that is observed throughout the 
course of infection to increase blood flow to the LN and facilitate adaptive immune 
response on-set will be addressed. In turn, data that address such a hypothesis will 
provide new and vital insight into LN vascularity and its impact on cellular trafficking 
and induction of effective immune response. Furthermore, it will be a starting point from 
which to continue to dissect the mechanism of arteriole remodeling within the lymph 
node and begin to appreciate its immune regulatory action and resulting therapeutic 
potential and represents an interdisciplinary approach linking immunity, vascular 
physiology, and microcirculation in the context of infection. 
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CHAPTER TWO - METHODOLOGIES 
2.1 Herpes Simplex Virus Type II Pathogenesis 
Herpes Simplex Virus Type II (HSV-2) was used as an infection model throughout 
experiments. HSV-2 represents an excellent and significant model in which to study 
vascular changcs during infection, as it is a physiologically relevant model of a sexually 
transmitted infection (STI). STI's arc a significant area in that they continue to be a 
pathological burden throughout the world; In fact, globally, the infection rate of sexually 
transmitted infections is staggering and exceeds 400 million adults per year. HSV-2 itself 
is estimated to infect one in every five individuals in the USA alone and can manifest as 
genital herpes as well as frequently fatal neonatal disseminated herpes or herpes 
encephalitis (Fleming et al, 1997, Handsfield et al., 1999). Notably, the development of 
genital herpes is also an important cofactor in IIIV-1 transmission via increased numbers 
of T cells and DCs susceptible to HIV-1 infection during and following HSV-2 
ulcerations (Zhu et al, 2009). This association thereby makes HSV-2 infection rates a 
contributing factor to the global HIV pandemic (Cameron et al, 1989, Stamm et al, 1988, 
Freeman et al., 2006), which presents an alarming threat to human lives and highlights 
the need for further study of STI's in general and supports the use of HSV-2 as an 
infectious model for this study. Furthermore, the persistence of STI's also speaks to a 
need to use multi-faceted studies to appreciate different interacting aspects of sexually 
transmitted infections in order to expand our understanding of pathogenesis and/or 
elucidate potential new therapeutic avenues (Mcdzhitov, 2009). Additionally, using an 
infection model such as HSV-2 is useful as it is well established and any observed 
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changes or phenotypcs within the vasculature will be able to be correlated with what is 
already known about HSV-2 pathophysiology. 
The general pathophysiology of HSV-2, a member of the hcrpesviridae family, 
demonstrates it to most commonly manifest as genital herpes and present clinically with 
vesicular lesions and pustules on the epidermis within two to ten days from primary 
infection. The virus infects and replicatcs in the mucosal epithelial cells as well as in 
neurons innervating the infected area. Neurons arc also the site of HSV-2 latency, 
specifically the sacral root ganglia, thereby establishing a viral reservoir for the virus that 
enables recurrence. Although both humoral and cell-mediated immunity are mounted 
during infection, these responses are not sufficient to clear the virus. Currently, there is 
no vaccine against HSV-2, and treatment for individuals infected is the use of anti-viral 
agents, such as Acyclovir. However this treatment does not clear the virus, but does work 
to decrease symptom severity and frequency of recurrence (Grecnberger, 1998). 
Upon infection of the genital mucosa with HSV-2, the virus is recognized by 
components of the innate immune system. Given the high number of CpG motifs in the 
HSV-2 genome, HSV-2 is most frequently recognized through TLR 9 by antigen 
presenting cells (APCs) within the genital mucosa (Lund et al., 2003, Sato et al, 2006). 
Antigen presenting cells then traffic to and present antigen in the draining lymph nodes 
(Murphy et al2008). The draining lymph nodes of the genital mucosa are the iliac and 
inguinal lymph nodes and arc the site of induction of adaptive immune response to an 
HSV-2 infection of the genital mucosa. Conveniently, HSV-2 can be given intra-
vaginally (i.vag.) in murine models, which opens the possibility of studies to using a host 
of murine genetic models, and allows the study to be conducted within a biologically 
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relevant infection route as HSV-2 given i.vag. will drain the inguinal lymph node, which 
is an accessible and established site of intravital microscopy (IVM) study of LN 
vasculature (Soderbcrg et al., 2005, Overall, 1975). 
2.2 Infectious Model & Immunization Protocol 
To achieve consistent infection, mice were treated with Depo-Provcra 
(medroxyprogesterone acetate at 5mg/mouse) five to seven days prior to infection by 
subcutaneous injection in the ruff of the neck; Depo-Provera induces a diesterous phase 
and significantly increases susceptibility to HSV infection (Baker et al., 1978, Kaushic et 
al., 2003). Subsequently, Depo-Provera treated female mice were intravaginally (ivag) 
infected with 106 pfu of thymidine kinase mutant HSV-2 strain 186TKAKpn (TK'HSV-
2). Virus was diluted in sterile phosphate buffered saline (PBS) to give a concentration of 
106pfu/10[.il. Prior to infection, mice were given a dose of sodium pentobarbital 
(90mg/'kg by i.p. injection). The vaginal mucosa was then swabbed with a calcium 
alginate swab moistened with sterile phosphate buffered saline (PBS). Virus was then 
introduced via pipette tip and the mouse was propped with its hind end upwards for 
approximately twenty minutes and allowed to recover from anesthetic. 
TK'HSV-2 was a generous gift from Dr. Akiko Iwasaki at Yale University School 
of Medicine with permission for use given by Dr. David Knipe at Harvard Medical 
School. Virus was propagated by inoculation of Vero cells with virus stock and then 
allowing for viral replication. Cells were then harvested and lyscd by sonication. Viral 
titer on the lysate was determined in plaque forming units (pfu) using Vero cells. The 
same viral stock was used throughout the project and had a titer of lxl09pfu/ml. Tk'HSV-
2 is an attenuated strain of HSV-2 that lacks the thymidine kinase gene, which prevents 
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reactivation of the virus from latency and is non-lethal to mice. From a vascular study 
perspective this is important as it allows for the vasculature to be studied for a lengthy 
period without worrying about mortality to the animal, as well as allows focus on a single 
infectious event opposed to determining if a vascular response was due to the primary 
infection or recurrence. Furthermore, TK'HSV-2 is sufficiently immunogenic that 
subsequent immunization with wild-type virus shows mice to be resistant to rechallange 
as demonstrated by a 10-fold increase in lethal dose of virus. This means that the same 
model could be used to study vascular changes during re-challenge in the future 
(McDermott et al., 1984, Jones et al, 2000, Parr et al., 1994). 
2.3 Intravital Microscopy 
While progress is being made in developing alternative techniques, intravital 
microscopy (IVM) has long served as a vital tool in visualizing immune response in vivo. 
IVM has been conducted in a multitude of tissues including pancreas, brain, skeletal 
muscle, liver, and lymph nodes. In terms of the type of IVM used to study the 
microvasculature, our group has found in practice that while two-photon offers 
advantages in the depth of tissue that can be imaged as well as the increased data analysis 
capabilities, bright-field and epi-fluorcscent IVM have greater flexibility in the location 
of preparation due to a lack of need for water or oil immersion, complete immobilization 
of the preparation area, or a flat preparation allowing for cover slip application. 
Regardless of the type chosen, intravital microscopy is an indispensable tool in studying 
vasculature in vivo. It provides for real-time, in vivo imaging; the result of a disease 
process or new therapeutic on tissue function can be directly visualized. In terms of 
vascular supply, it allows for study of vessel functionality, flow dynamics, integrity, and 
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vessel number among others, all in the in vivo context which the vasculature functions 
everyday. Most importantly for this study, IVM lends itself well to use at further 
investigating microcirculation in immune response in terms of LN vascularity due to the 
existence of preparations of a number of lymph nodes including the popliteal, cervical, 
and inguinal nodes (Sumen et al, 2004, Mempel et al, 2004, Germain et al., 2006). In this 
study a preparation of the inguinal lymph node was utilized, as it is a draining lymph 
node for infection of the vaginal mucosa. Animal preparation, surgical procedure, and 
methods for creating a profile of the vasculature arc given below. 
Animal preparation. Sodium pentobarbital was administered at an initial dose of 
90mg/kg by intraperitoneal (i.p.) injection. Drug effect was monitored throughout the 
experiment by via response to toe pinch. Subsequent doses of drug were given as needed 
at 20mg/kg. Hair was shaved from the abdomen and hip area of the mice and swabbed 
with alcohol . Mice were subsequently placed supine on a clear custom surgical board. 
Surgical Procedure. Surgical procedures were performed under a standard 
dissecting microscope. A midline incision was made along the ventral surface of the 
abdominal cavity and the skin was retracted towards the spine. The resulting skin flap 
was pinned onto a clear Sylgard 184 pad. Subsequently, the layer of connective tissue 
surrounding the LN was removed and overlaying adipose tissue was cleared until the 
microvasculature was exposed. When required, the main lymph node venule was 
manipulated to allow visualization of the main feed arteriole (Figure 1). Throughout the 
surgical preparation, tissue was constantly kept moist with bicarbonate-buffered 
physiological salt solution (PSS) (pH 7.4, 37°C, 131.9mM NaCl, 4.7mM KC1, 1.2mM 
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MgS04-7H20, 2mM CaCh^HbO, 18mM NaHCCh) that had been equilibrated with 5% 
CO2 - 95% N2 for at least one hour. 
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Figure 1: Inguinal Lymph Node Preparation. Schematic diagram of intravital 
microscopy preparation of the inguinal lymph node feed arteriole with 
progression shown from left to right. First, the mouse is place supine and a 
midline incision is made and dissected back towards the spine to create a skin 
flap. The flap is made and pinned out to expose the lymph node and the 
overlaying fat pad. Finally, the overlaying fat pad and connective tissue is 
dissected to reveal the lymph node arteriole (red) and venule (blue). 
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Vasoactive profiles. Oncc completed, the preparation was secured on a modified 
Nikon Eclipse intravital microscope and the feed arteriole was observed at a total 
magnification of 950x using video microscopy. The preparation was constantly 
superfused with PSS maintained through a water-jacket heated reservoir at 32-37°C. 
Vessel diameters were determined from the width of the red blood cell column using a 
video caliper. The same vessel segment was studied in each mouse per group. The resting 
vessel diameter was measured following sixty minutes of equilibration with PSS. The 
effect of a smooth muscle-specific agonist phenylephrine (PE) (Sigma-Aldrich, catalog 
T6126) was evaluated by cumulative addition (InM to lOjiM) to the superfusate. At each 
concentration, the stable arteriolar diameter was recorded before the next increment. The 
preparation was then superfused with control PSS to recover for approximately thirty-five 
minutes and additional agonists were subsequently evaluated. When the preparation was 
equilibrated with L-NAME to inhibit NOS, L-NAME was prepared fresh at lOOuM (pH 
7.4) in PSS and superfused over the preparation for sixty minutes with vessel diameter 
recorded at 0, 30, 45, and 60minutes. Maximal vessel diameter measurements were 
obtained by equilibrating the preparation with lOO^iM sodium nitroprusside (SNP, Fluka, 
catalog "71780) or 30^M Nifedapine (Sigma-Aldrich, catalog #N7634). A representative 
image of the IVM imaging set-up and typical image projected from the 1VM microscope 
is given below (Figure 2A,B) (Sellers & Payne, 2011). In cases where fluorescence was 
used for imaging of the lymph node feed arteriole, 1% w/v fluorescein isothiocyanate 
dcxtran (FITC-dextran) was prepared in IX sterile phosphate buffered saline (Invitrogen, 
catalog "20012043). FITC was given inter-cardiac at a dose of lOOul per mouse and 
allowed to circulation for approximately ten minutes prior to imaging. Imaging was 
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conducting using filters and a mercury lamp adapted to the IVM scopc used in all other 
experiments. At the end of IVM imaging, micc were euthanized by overdose of sodium 
pentobarbitol followed by cervical dislocation. 
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Figure 2: Intravital Microscopy Lymph Node Imaging. A. Typical IVM microscopc 
set-up. B. IVM image of inguinal lymph node feed arteriole (red arrow and red 
false colouring) feeding the lymph node equilibrated with physiological saline 
solution and running along side the main venule (green arrow). Images are 
frames from Sellers & Payne, 2011. 
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2.4 Animal Models and Animal Care & Use 
Micc models were used throughout as the IVM model of the inguinal lymph node 
used in initial previous studies (Sodcrberg, 2005) relied on murine models, and murine 
models provide a number of important genetically manipulated models to use in 
dissecting the mechanism of vascular changes in the LN. C57 BL/6J mice (WT, stock 
#000664) were used as a wild-type base and were purchased from The Jackson 
Laboratory (Bar Harbor, Maine). For genetically manipulated mouse models, CD4 T cell 
deficient mice (CD4 ~, B6.129S2-C'D4<tmlMak>/J, stock *002663), endothelial nitric 
oxide synthase deficient mice (eNOS"\ homozygous B6.129P2-NOS3<tmlUne>/J, stock 
°002684), mast cell deficient mice (compound heterozygous WBB6Fl/J-Kit<W>/Kit<W-
v>/J, stock #100410), caveolin-1 deficient mice (homozygous cavl<tmlMls>/J, stock 
#004584), and tumor necrosis factor alpha deficient mice (Tnfcx"homozygous B6.129S-
Tnf<tmlGKl>/J, stock "005540 were purchased from The Jackson Laboratory. 
Additionally, homozygous eNOS"" breeder pairs were also purchased from The Jackson 
Laboratory and bred in the Northern Health Sciences Research Facility (NHSRF) at 
UNBC. Mice deficient in L-selectin (L-selectin"'") were a generous gift from Dr. Klaus at 
the La Jolla Institute for Allergy & Immunology. Adult mice were used at 8 to 20 weeks 
of age. Micc were considered old at greater than 18months of age. Regardless of strain, 
all mice used were female given that virus was administered intra-vaginally. 
All mice were housed for a minimum of one week after arrival at the NHSRF at 
UNBC before experimental use to eliminate effects due to stress of shipping. Micc were 
housed at 22°C in with a 12 hour light / 12 hour dark cycle and were permitted free 
acccss to food (Rodent LabDiet 5001) and water. They were inspected daily for adverse 
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reactions to experimental treatments and used at > 8 weeks of age. All procedures were 
approved by the University of Northern BC Animal Care and Use Committee (approved 
under current protocol A2010.0924.03( 1)). 
2.5 Pharamcological treatments 
In order to support results from genetic ablation models, pharmacological 
treatments were used. Specifically, in the cases in which CD4r T cells and eNOS were 
ablated, pharmacological systcmic treatment with antibody against CD4 and systemic 
treatment with a global nitric oxide inhibitor were used respectively. 
CD4 Depletion. Female C57 BL/6 mice were used for CD4+ T cell depletion 
studies. Mice were treated with antibody by intraperitoneal injection of 0.2mg of 
functional grade anti-mouse CD4 (L3T4, eBioscience, catalog "16-0041). Initial 
injections were given four days prior to infection and were repeated two days prior to and 
two day after infection. This protocol has previously been demonstrated to be effective 
for CD4+ T cell depiction in the context of HSV-2 infection by Dr. Yusuke Nakanishi in 
Dr. Iwasaki's laboratory. However, similar protocols have also be shown to be effective 
in depleting circulating CD4' T cells in the context of infectious models by other groups 
(Wozniak et al., 2011, Matloubian et al., 1994) including during HSV infection of C57 
BL/6 mice (Jennings et al., 1991). 
L-NAME Treatment. Female C57 BL/6 mice were treated with Nitro-L-arginine 
methyl ester hydrochloride (L-NAME, Sigma-Aldrich, catalog "N5751). L-NAME was 
dissolved in drinking water at a concentration of0.5mg/ml changed daily. This method 
has been shown to be effective at blocking NOS expression in the context of vascular 
remodeling and lymphocyte accumulation in asthma models in the lung the by Bhandari 
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et al. (2006). Treatment was administered for fourteen days prior to initial treatment with 
Depo-Provera and continued throughout the course of Depo-Provera treatment and 
infection. 
2.6 Histology & Tissue Samples 
Tissue samples were collected for further analysis. Tissues collected included 
inguinal and iliac LNs and individual lymph node feed arterioles. LNs were collected 
from euthanized mice and stored in 5% buffered formalin. Lymph node feed arterioles 
were collected from anesthetized mice; once exposed, the lymph node feed arteriole was 
briefly superfused with 100j,iM SNP to induce maximal dilation and then was superfused 
with 5% buffered formalin and clamped with forceps. The arteriole was then carefully 
dissected out and stored in 5% buffered formalin. Arterioles used for IVM imaging and 
treated with vaso-active drugs such as phenylephrine or L-NAME were not used for 
tissue collections. 
Feed arteriole samples were shipped to Wax-it Histology Services Inc. (Vancouver, 
BC, www.waxitinc.com) for paraffin embedding, sectioning and staining. For each data 
point, a minimum of three arterioles from separate animals were processed. Sections were 
imaged using a standard light microscope, 
2.7 Statistical Analyses 
All statistical analyses were performed with GraphPad Prism 5.0 (GraphPad 
Software, San Diego California USA, www.graphpad.com). Data was analyzed using 
one-way and two-way repeated-measures analysis of variance with Bonferroni and 
Dunnctt's Multiple Comparison post tests, and paired T-tcsts with statistical significance 
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defined as *p<0.05, **p<0.01, and ***p<0.001. Specific N-values for arteriole diameters 
and response to vaso-active drugs arc all greater than or equal to three, with specific re­
values given in each figure. 
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CHAPTER THREE - Vascular Profile of Lymph Node Feed Arteriole During 
Infection 
3.1 Introduction 
Elucidating the mechanisms controlling the on-set of adaptive immunity is an 
ongoing goal of researchers across the globe as every new aspect of understanding 
presents novel therapeutic insights into how to initiate an adaptive response more quickly 
and/or robustly. Previous research on induction of adaptive immune response has often 
focused on LNs, as they arc the main sites of antigen presentation by APC to naive T 
cells (Murphy et al., 2008). In fact, given the rarity of antigen specific naive T cells, 
approximately only 20-200 CD4f T and 20-1200 CD8" T cells in a C57 BL/6 mouse are 
antigen specific, the search for cognate lymphocytes by APC in LNs is rate-limiting in 
production of effector cells needed to fight infection (Obarr et al., 2010, Obarr et al., 
2008), with the time required for the production of ThI effector responses being inversely 
proportional to the number of cognate lymphocytes in the LN (Soderberg et al., 2005). 
Therefore, based on the scarce nature of cognate lymphocytes, most past studies aimed at 
understanding induction of robust adaptive response have focused on determining factors 
that allow for efficient screening of lymphocytes within the LN. Subsequently, given that 
a high screening rate for cognate T cclls would necessitate high input, and that the 
majority of trafficking cells enter the LN from the blood and exit through the afferent 
lymph (Hall, 1974, Hay & Hobbs, 1977), studies of LN vascularity are common within 
those examining adaptive immune response on-set. 
Vascularity studies within reactivc LNs began with general reports of hyperemia 
and identification of areas within the LN with increased vascularization (Hay & Hobbs, 
1977, Herman et al., 1972). Studies then progressed to focus on specific vessel types, 
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with the majority of studies centering on HEVs. This led to an extensive understanding of 
homing and trafficking across HEVS (von Andrian & Mcmpel, 2003) and conflicting 
reports of HEV expansion, proliferation, and arborization (Anderson et al., 1975, Liao & 
Ruddle, 2006, Mcbius et al., 1990, Myking, 1980, Soderberg et al., 2005). However, the 
impact of upstream microvasculature, at the level of the feed arteriole, in the immune 
response remained unexplored prior to a recent study by Sodcrbcrg and colleges (2005), 
which demonstrated that lymphocyte accumulation occurred as a result of an increase in 
blood supply via expansion of the primary feed arteriole to the draining LN; The LN 
arteriole remodeled to an -50% greater diameter three days post-immunization (p.i.) with 
Herpes Simplex Virus Type II (HSV-2). Such an increase in blood flow into the LN 
would theoretically increase the rate of screening for rare cognate lymphocytes from 
3xl06 to 14xl06 cells/day (Soderberg et al., 2005), which given the rate-limiting nature of 
screening for cognate lymphocytes, justifies further study of arteriole remodeling. 
Arguably, the best place to begin is to investigate LN arteriole remodeling further is 
to determine the kinctics, magnitude, and nature of remodeling as understanding these 
characteristics would better allow for links to be make to what is already known about 
immune and vascular response within reactive LNs. For example, in the ease of HSV-2 
infection in the genital mucosa, presentation of antigen occurs on MHC II to naive CD4* 
T cells in the inguinal and iliac lymph nodes by DCs migrating from the periphery into 
the LN through lymphatics within hours of immunization (Grecnbcrg et al., 2008, 
Kumamoto et al., 2011 Sodcrbcrg et al., 2005). This is followed by screening of cognate 
lymphocytes and cellular accumulation within the lymph node with increased cellularity 
and LN hypertrophy noted to continually increase until at least five days following 
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infection (Soderberg et ai, 2005). Successful induction of adaptive immune response 
gives rise to primed CD4' and CDS' cffcctor cells which begin migrating into the 
infection site at days three to four and four to five respectively following infection 
(Nakanishi et ai, 2009), with subsequent resolution of LN hypertrophy. If the profile of 
LN arteriole expansion does not correspond to the dynamics of the immune response 
noted above, this would suggest a mechanism driving expansion independently of those 
involved in induction of adaptive response in the LN. However, the opposite is also a 
possibility; correlation to the timeline of immune response to IISV infection would 
suggest an immune based mechanism driving arteriole expansion. 
An immune driven mechanism following the course of infection is also supported 
by studies of HEVs as changes in HEVs following the course of infection are dependent 
upon B cells and DCs (Angell et ai, 2006, Liao & Ruddle, 2006). Total HEV surface 
area, quantified by antibody staining, was noted to increase following immunization 
(Mebius et ai, 1990), with Soderberg (2005) and colleges reporting an increase in HEV 
number proportional to increase in LN size until at least day four after infection. 
Additionally, an increase in internal HEV diameter, increasing rapidly after immunization 
to a peak of 3-times greater at day three, with subsequent decrease to baseline diameter 
by day twelve with little change to vessel wall thickness (Myking, 1980). This pattern of 
increasing vascularity soon after infection with eventual resolution in HEVs also holds 
for studies of general LN vascularity and lymphatic vessels. Tracing of blood-borne 
microbcads indicate that blood flow to the LN rapidly increases following infection and 
remains elevated for at least five days, with increased blood flow correlating to increased 
LN weight. Microangiography also noted increased vascularization within a day of 
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immunization with a peak at day five that subsequently returned to baseline level 
(Herman et al., 1972). A similar pattern was seen in the microvasculature of dLNs of skin 
allographs in which increased vascular permeability is noted as early as twelve hours 
with peak vascularization around seven days (Anderson et at., 1975). Day seven was also 
noted as the peak time-point of generalized vascular growth within reactive LNs, as 
indicated by endothelial cell proliferation, and was linked to DCs by Webster and 
colleges (2006). Collectively, these past studies of HEVs and general LN vasculature 
indicate vascular changes throughout the course of infection are dynamic, follow the 
pattern of adaptive immune on-set and have keys links to the immune response. 
Therefore, based on the previous findings within the LN in terms of lymph vessels, 
HEVs, and general vascular growth, the hypothesis that arteriole remodeling would also 
change throughout the course of infection, peak shortly after the time-point of effector 
cell migration to the infection site, and then return to baseline was formed. This 
hypothesis was furthered to include the hypothesis that remodeling of the feed arteriole 
was an outward euthrophic event, based on studies of HEVs by Myking (1980) and that it 
would be the most effective remodeled state by which to increase blood supply to the LN 
and expedite delivery of naive lymphocytes, as arteriole expansion was shown to 
facilitate trafficking by Soderberg and colleges (2005). 
To address the hypothesis that arteriole remodeling, like HEVs and general 
vascular growth, correlates to changcs in lymph node cellularity and generation of 
effector cells, IVM experiments aimed at determining the kinetics and magnitude of 
arteriole remodeling throughout the course of infection were conducted. Results from 
these experiments were considered in the context of how they correlate to what is know 
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about the immune response and other vascular changes within the LN. Investigations 
demonstrate arteriole expansion to commence as early as day one following infection and 
peak at day seven post infection, following which arteriole diameter returns to pre-
infection size. To address the second hypothesis, of outward eutrophic remodeling, H&E 
stained cross-sections of isolated LN arterioles from multiple time-points after infection 
were analyzed, with results supporting the hypothesis of outward eutrophic remodeling. 
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3.2 Results 
Bright-field intravital microscopy was used to examine the inguinal LN feed 
arteriole of C57 BL/6 mice at multiple days after i.vag. infection with Tk HSV-2. From a 
baseline average diameter of 85|im at day zero of infection, a significant increase in the 
resting vessel diameter was notable as early as one day post-immunization (p.i). Resting 
diameter subsequently continued to increase until seven days p.i., peaking at a average 
diameter of 165|im. After this peak, the resting diameter declined and returned to a value 
not different than that seen prior to infection. This was quantified by measurement of the 
vessels (Figure 3A) and could also be observed via gross examination of equilibrated 
feed arterioles (Figure 4A). 
Maximal vessel diameter was found to have the same temporal pattern of 
remodeling as resting diameter. Compared to the average baseline diameter at day zero of 
117[.im, there was a significant increase in maximal diameter by day one p.i. to an 
average of 142jam. Maximal diameter continued to increase until peaking at seven days 
p.i. with an average diameter of 187f.un before returning to a baseline diameter. As with 
the resting diameters, these significant increases were notable when comparing measured 
vessel diameter (Figure 3B) as well as comparison of microscopic images of the feed 
arteriole vessels following supervision of the applied vasodilator (Figure 4B). 
Additionally, the maximal diameter of the feed arteriole returned to the same diameter as 
that seen prior to infection. 
Together, the resting and maximal diameters demonstrate a pattern of increase in 
vascular supply to the lymph node during infection, which returns to levels seen prior to 
infection following induction of an adaptive immune response. In both cases, resting and 
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maximal diameters, maximum vascular growth is seen seven days p.i.. At this point of 
maximal remodeling, the increase in vascularity represents a 100% increase in resting 
vessel diameter set-point and a 70% increase in the maximal vessel size when compared 
to that of an uninfected mouse (Figure 3C). 
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Figure 3: Wild-Type Lymph Node Arteriole Resting and Maximal Diameters 
Throughout Infection. A. Resting arteriole diameter at days zero, one, three, 
five, seven, nine, and thirty-five (5 weeks) after i.vag. infection with TK'HSV-
2. B. Maximal arteriole diameter at days zero, one, three, five, seven, nine, and 
thirty-five (5 weeks) after i.vag. infection with TK"HSV-2. Maximal vessel 
diameters were recorded after superfusion of lOOj-iM SNP. C. Resting and 
maximal vessel size at day seven p.i. relative to day zero p.i. expressed as a 
percent change. Data represents mean diameter (A,B), and percentage of mean 
day zero diameter (C) ± SEM wherein n-11, 5, 6, 5. 5, 4, and 4 animals for 
days 0, 1,3, 5, 7, 9, and 35 respectively where one arteriole was studied per 
animal. *p<0.05, **p<0.01, and ***p<0.001. 
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Figure 4: Intravital Microscopy of Wild-Type Lymph Node Arterioles Throughout 
Infection. A. Representative images of resting diameter arterioles following 
infection at days zero, three, and seven after infection. B. Representative 
images of maximal diameter arterioles following infection at days zero, three, 
and seven after infection and application of SNP to the preparation. In all 
images, the arteriole, which is indicated by green arrows, is shown to the left of 
the LN venule. 
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At all days post immunization, there is a notable difference in resting and maximal 
vessel diameters (Figures 3A, B), which demonstrates the ability of the vasculature to 
respond to an applied vasodilator. This speaks to the health of the studied vessels and the 
success of the preparation. However, wc also wanted to consider the preparation integrity 
and vasoactive capability of the feed arteriole using phenylephrine (PE), a SMC «i-
adregeneric receptor agonist. A dose response curve from 10"9 through to 10"" M PE in 
physiological saline solution superfused over the preparation was conducted. Uninfected 
day zero wild-type controls showed dose-dependent vasocontriction; less than one 
percent constriction was seen at the lowest concentration of 10~9M, but increased 
significantly, in a dose-dependent manner, and peaked between 50-60% constriction with 
application of 10"5M PE. Figures 5A and 5B show percent constriction relative to resting 
diameter and representative images respectively from the dose response curve. Next, to 
both evaluate the health of the preparations as well as investigate potential changes in 
smooth muscle response, phenylephrine response curvcs were conducted at days one, 
three, five, seven, nine, and thirty-five p.i.. Infected mice at all days showed no 
significant difference in percent vessel constriction compared to uninfected day zero 
controls at any concentration of PE (Figure 5C). Therefore, the dosc-dcpendent response 
to PE and the consistency of the constriction throughout the course of infection support 
the health of the preparation and indicate that no change is seen in vascular response 
during infection in wild-type mice. 
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Figure 5: Wild-Type Lymph Node Arteriole Vascular Response to Phenylephrine 
During Infection. A. Percent vessel constriction with respect to resting vessel 
diameter of LN arteriole of wild-type mice at day zero p.i. in response to 
superfusion PE applied in fold increases from 1CT9 to 10"5M. B. Representative 
images of lymph node arterioles following at day zero p.i. prior to PE 
application and following superfusion of 10"9, 10"7, and lO'^M PE. In each 
image the arteriole is shown to the upper right of the LN venule and indicated 
by a green arrow. C. Percent vessel constriction with respect to resting vessel 
diameter of LN arteriole of wild-type at day zero, one, three, five, seven, nine, 
and thirty-five p.i. in response to PE applied in fold increases from 10"9 to 10" 
~M. Data represents percent constriction (A,C) ~t SEM were n=6 for day zero 
and n^5 animals for days one, three, five, seven, nine, and thirty-five where 
one arteriole was studied per animal. *p<0.05. **p<0.01, and ***p<0.001. 
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Changes in vessel diameter can occur in a number of ways, such as those discussed 
above in the introduction, however, given that the blood columns and vessel walls were 
visible during imaging and the blood columns appeared to be much larger following 
infection without increase in vessel wall thickness (Figure 4). These findings 
subsequently lead to the hypothesis that the arteriole expanded by outward remodeling 
without any neointimal formation. To address this hypothesis, cross-sections from days 
zero, seven, and thirty-five were H&E stained (Figure 6). All stained sections showed 
similar wall thickness throughout the course of infection, thereby supporting outward 
eutrophic arteriole remodeling. 
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Figure 6. H&E Staining of Wild-Type Lymph Node Arteriole Sections During 
Infection. LN arterioles treated with lOOuM SNP and isolated from 
anesthetized mice and then fixed in 10% buffered formalin and then embedded 
in paraffin. Sections were H&E stained and imaged at 400x using a standard 
light microscope. Representative images are shown for days zero, seven, and 
thirty-five following infection, where the vessel wall is indicated by the blue 
arrow and the adventitia is indicated by the red arrow. 
49 
50 
3.3 Discussion 
These experiments arc the first to demonstrate and characterize reversible 
remodeling of the LN feed arteriole during infection. These findings show that 
remodeling is first notable day one p.i., and that expansion continues until day seven p.i. 
following which diameter begins to return to a size similar to that seen prior to infection. 
The complete characterization of the kinetics and magnitude of arterial remodeling is 
vital; it allows for connections to be made between changes to the feed arteriole and other 
events within the lymph node. The timeline of remodeling, being noted as early as day 
one p.i., and continuing until day seven p.i., supports the hypothesis that arteriole 
remodeling aids the induction of adaptive immune response as the process of remodeling 
mirrors the timeline of adaptive immune response (Murphy et ai, 2008) including the 
generation of antigen specific effector cells (Nakanishi et ai, 2009) and the mechanism 
of facilitating T cell migration to the lymph node as cellular accumulation within the 
node as well as rate of lymphocyte accumulation and organ hypertrophy has been shown 
to increase soon after immunization with Tk"HSV-2 and continue until at least day five 
p.i. (Soderbcrg et ai, 2005). 
Beyond corresponding to the timeline of immune response, arteriole remodeling 
also resembles other patterns of vascular growth noted within the LN including 
generalized growth and changes in HEVs. Reactive HEVs have been shown to have a 
spike in internal diameter that starts within a day, spikes, and returns to baseline around 
twelve days following stimulation (Myking, 1980), while other studies demonstrate HEV 
numbers to increase proportional to LN size until at least day four following infection 
with HSV-2 (Soderbcrg et ai, 2005). Stimulation with oxazolone, an immunological 
adjuvant commonly used to induced hypersensitivity reactions, also resulted in increased 
HEV area spiking around day four before returning to baseline (Mcbius et ai, 1990). 
Additionally, early studies show increased capillary diameter and density within twenty-
four hours following stimulation, increasing through day five followed by return to prc-
stimuiated state (Herman et ai, 1972). Furthermore, Hays & Hobbs (1977), based on 
microsphere accumulation and cardiac output, suggest that increased blood flow to 
draining lymph nodes is the result of hyperemia for the first twenty-four hours and 
subsequently the result of vascular growth over the course of more than four days. 
Therefore, comparing new findings presented here to the time-course of immune 
response seen during HSV-2 infection, and previously noted kinetics of HEV and LN 
vascular changes during immune response, implies that the mechanism of arteriole 
remodeling is induced by cells that migrate early during infection or are resident in the 
lymph node and that the mechanism governing HEV expansion and proliferation may 
also be key in facilitating arteriole expansion. 
The mechanism of arteriole remodeling was partially indicated by H&E staining of 
arteriole cross-sections shown above. The finding of reversible outward euthrophic 
remodeling was exciting, as although changes in vascularity have been shown to occur in 
other vascular beds during infection, in all cases this is pathogenic and irreversible. For 
example in chronic inflammation, which can be the precursor to many diseases such as 
airway disease, where arterioles, capillaries and venules arc all pathogenically and 
chronically enlarged (Ezaki et ai, 2001) or in pulmonary arterial remodeling in response 
to hypertension (Daley et ai, 2008). In contrast, remodeling of the LN arteriole is not, as 
highlighted by the return of vessel diameter to baseline that coincides with the clearance 
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of infection. This also partitions arteriole remodeling into two distinct phenomenon: 
expansion and reversion to homeostatic size. The first phase, expansion, which was 
shown to occur via outward eutrophic remodeling, may first involve hyperemia with 
subsequent vascular growth. Hays & Hobbs (1977) first proposed this model within the 
lymph node based on two distinct spikes in LN blood flow, the first is noted as early as 
one and a half hours after stimulation and peaks around fourteen hours and the second 
begins around day two p.i. and continues past day four p.i. and was based on the kinetics 
of endothelial cell division. The concept of early hyperemia is also supported by data that 
will be detailed in subsequent chapters that reveal a role of inflammatory mediators 
within the LN feed arteriole and shifts in resting arteriole diameter. Vascular expansion 
following initial hyperemia is further supported by studies that show ECs numbers to 
increase in the LN by day three and peak at day seven following stimulation. However, 
BrdU was incorporated in the LN within the first twenty-four hours and increased 
through to day five, indicating the events of EC proliferation in the LN occurs early after 
stimulation and increases in correspondence with the timeline seen here in arteriole 
remodeling. Interestingly, the same study subsequently demonstrated EC proliferation to 
be dependent upon dendritic cells, L-selectin, and VEGF, all of which will be considered 
and discussed in subsequent chapters (Webster et al., 2006). Additionally, and notably, 
ECs proliferation within the stimulated LNs was also shown to be present in both PNAd^ 
(eg. HEVs) and PNAd (eg. arteriole, lymphatics) cells within the LN, which supports the 
potential for ECs proliferation within the LN arteriole during remodeling (Chyou et al., 
2008). 
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Kinctics of endothelial cell division and vascular changes in non-LN settings also 
correspond to the current findings within the LN feed arteriole. For example, in the 
context of infection leading to inilammatory airway disease, increased arteriole diameters 
peaked seven days following infection and was accompanied by increased EC 
proliferation indicated by BrdU incorporation which peaked five days after infection and 
stopped at day nine (Daley et ai, 2008, Ezaki et ai, 2001). Similar patterns are also seen 
in angiogencsis where proliferation has been shown to peak around day three and persist 
through day six in the context of both graft-vcrsus host and hypersensitivity type immune 
responses (Polverini etal., 1977, Sidky et ai, 1975). Beyond endothelial cell 
proliferation, EC hypertrophy as also been noted in HEVs following stimulation, which 
subsequently returned to baseline (Myking, 1980) and is also an indicator or rapid EC 
proliferation (Ezaki et ai, 2001). Therefore, a general conclusion that the dynamics of 
EC proliferation and hypertrophy, as noted within the LN and in other non-LN 
environments, corresponds to the timeline of arteriole remodeling within the LN can be 
drawn. This is an important conclusion as outward eutrophic remodeling, as is observed 
in the LN arteriole, would require increased EC size or number. As such, this supports the 
future hypothesis that LN arteriole remodeling is driven by EC proliferation, hypertrophy 
and/or recruitment. 
The second part of the arteriole phenomenon, return to baseline diameter, is just as 
interesting as the expansion of the arteriole, because while understanding how to induce 
and augment or inhibit remodeling would allow for control of on-set of adaptive 
immunity, learning how the process is reversed would provide new therapeutic insight; in 
most cases of outward vessel remodeling, including inflammatory airway disease and 
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pulmonary hypertension (Daley et al., 2008, Ezaki et al., 2001) the event is a largely 
permanent process and associated with vascular dysfunction and disease progression. 
Therefore, understanding how arteriole remodeling within the LN is reversible, may 
allow us to generate new theories on how to reverse pathological forms of remodeling. 
However, while the potential mechanism driving arteriole expansion will begin to be 
addressed in subsequent chapters of this thesis, how expansion occurs with subsequent 
return to baseline occurs is a planned future direction. As the current hypothesis proposed 
was that expansion may occur through a combination of hyperemia, and endothelial cell 
proliferation, but studies to address these possibilities have yet to be completed, the 
exploration of mechanism of the LN arteriole return to baseline diameter first requires 
confirmation of the mechanism of expansion. As such, this will be addressed in the future 
directions section of the final chapter along with other factors that are important future 
considerations such as shear stress levels, blood flow rate, effect of different pathogens, 
and impact on adhesion molecules which will further add to the novel and notable 
findings of the extent and timeline of reversible arteriole remodeling of the inguinal LN 
feed arteriole following HSV-2 infection. 
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CHAPTER FOUR - CD4+ T-Cells in Lymph Node Arteriole Remodeling 
4.1 Introduction 
Having established the kinetics and magnitude of lymph node arteriole remodeling, 
coupled with its importance in facilitating cellular accumulation within reactive LNs 
(Soderberg et al., 2005), understanding how remodeling is initiated and maintained in the 
first place is important because facilitating faster and/or increased entry into lymph nodes 
would serve to decrease the duration of the rate limiting process of screening for cognate 
lymphocytes. In generating hypotheses for the mechanism governing remodeling of the 
LN feed arteriole, supporting evidence is derived from two general sources. First, studies 
looking at generalized vascular growth as well as HEV and lymphatic growth in LN 
during immunization, and second, studies discerning the mechanism of eutrophic outward 
remodeling. Here, we will focus on consideration of the first, studies looking at LN 
vascular growth. 
Studies of LN vascular growth are numerous. However, what is known about 
vascular remodeling within the lymph node is largely limited to the study of HEVs and 
generalized vascular growth. These studies highlight the mechanism of vascular growth 
within the LN and at the HEV level to be dependent upon dendritic cclls regulating 
VEGF levels (Webster et al., 2006) potentially mediated through the FRC network 
(Chyou et al., 2008) and B cells involving LTf5R cross-talk (Angell et al., 2006). 
However, when considering these studies for indication of the possible mechanism of 
arteriole remodeling, it is notable that HEVs have a distinct phenotypes (von Andrian & 
Mcmpel, 2003). This presents the possibility that the mechanism of remodeling of the LN 
arteriole may be different than those mechanisms implicated downstream of the arteriole. 
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Additionally, given that the feed arteriole is directly upstream of and feeds HEVs, the 
mechanism of arteriole remodeling may directly or indirectly drive changes in HEV 
phenotype and function during infection. For example, increased blood How from 
arteriole remodeling could alter shear stress levels, distribution of blood borne 
chemokines and inflammatory mediators, and migration of immune cclls all of which 
would act upon the HEV. Notably, the reverse theory is also a possibility; signaling and 
mediators of vascular growth may be transmitted upstream from the LN and/or HEVs to 
act upon the feed arteriole such as has been seen with VEGF secretion within the LN that 
subsequently acts upstream on the HEVs (Webster et al., 2006). However, determining 
the impact of arteriole remodeling on HEVs or vice versa and subsequent impact on 
cellular trafficking and induction of a robust adaptive immune response first requires 
uncoupling different levels of vascular growth of the LN (ie. LN cortex, HEVs, arteriole), 
which, in turn, requires first determining the specific mechanism driving LN arteriole 
remodeling and underscores the importance of the aim of this section of the study: to 
begin to elucidate mechanism of LN arteriole remodeling during infection. 
Despite the differences between HEVs and LN vasculature and the LN arteriole 
itself and no indication if changes in one (LN vasculaturc/HEV or arteriole) affects the 
other, this is the most relevant source upon which to base a hypothesis on the mechanism 
of arteriole remodeling given the paucity of information on the LN arteriole. Therefore, 
based on findings that indicate DCs, acting through VEGF, as key components in EC 
proliferation within draining LNs as well as HEV phenotypes, an original working 
hypothesis that DCs are a critical factor in LN arteriole remodeling was formed. 
However, the approach to examine this hypothesis was to determine the role of CD4 T 
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cells. This investigative plan was based on the fact that during induction of adaptive 
immune response naive CD4r T cells amass in the draining LN via movement through 
the LN feed arteriole and trafficking through the HEVs that are fed by the arteriole. This 
gives the large number of CD4f T cell moving through the arteriole access to directly or 
indirectly act upon the feed arteriole. Notably, T cells have been implicated in other 
forms of arteriole remodeling (Daley et al, 2008) and vascular adaptation (Burne et al, 
2001), including induction of arteriogenesis (Stabile et al., 2003). Furthermore, 
investigating the role of CD4! T cells would indirectly indicate a role of DCs, due to their 
extensive interaction in the LN, while at the same time potentially identifying a novel 
role of CD4+ T cells in vascular growth. Therefore, a new hypothesis, that CD4f T cells 
drive LN arteriole remodeling, was formed prompted by consideration of the extensive 
interactions that occur between DCs and CD4+ T cclls in the reactive LN, the central role 
of CD4+ T cells in adaptive immunity on-set and LN hypertrophy, and evidence of CD41 
T cell involvement in other forms of remodeling. 
Investigation of CD4f T cells is most strongly supported by its diverse and vital 
interactions and roles in the LN; during infection, LN are the main site of screening for 
antigen specific CD41 T cclls and subsequent T cell priming. This first involves entry of 
naive CD4* T cclls into the LN, which is dependent upon induction of T cell rolling 
along the HEV via L-selcctin (CD62L) expressed on the T cell binding to peripheral node 
addrcssin on the HEV luminal surface. Specifically, L-selcctin binds the sulfated sialyl-
Lewisx carbohydrate moiety of CD34 and GlyCAM-1. Subsequently, activation of the 
rolling T cell is induced by interaction of CCR7 with CCL21 and CCL19 and CXC12 
with CXCR4. Finally, arrest is mediated by the binding of LFA-1 to ICAMS on the HEV 
58 
(Ley et al., 2007, Miyasaka & Tanaka, 2004, Murphy et al., 2008, von Andrian & 
Mempel, 2003). Notably, in addition to this complex trafficking cascade, remodeling of 
the LN feed arteriole aids lymphocyte recruitment to the LN, and activation of toll-like 
receptors alone is sufficient to induce cellular accumulation and LN hypertrophy 
(Soderberg et al., 2005). Collectively, this speaks to the trafficking of T cell to LNs as a 
diverse interaction of the vasculature at both the arteriole and HEV level as well as 
immune signaling at the site of infection and within the LN. 
Once in the lymph node, CD4f T cells transiently interact with antigen presenting 
cells in the T ccll zones in the process of screening for rare cognate lymphocytes. This 
interface is facilitated by interaction of CD2, LFA-1 and ICAM-3 on the T cell with 
CD58, ICAM-1 & 2, and DC-SIGN respectively on dendritic cells. When a naive T cell 
is identified that corresponds to the peptide-MHC complex being presented by the DC, a 
conformational change occurs in LFA-1 as a result of signaling through the T ccll 
receptor (TCR), which stabilizes the T ccll to DC interaction. Subsequent co-stimulation 
of the T cell via interaction of CD28 on the T ccll with B7 molecules on the DC provides 
survival signals. DCs, as well as cytokines such as IL-2, IL-6, and IL-12, also regulate T 
cell differentiation. In the late stage of proliferation, activated T cells acquire effector 
functions, of which there arc a number of categories. The two main forms of CD4' T 
cells arc termed ThI and Tn2 cells and are frequently referred to as helper T cells due to 
their role in aiding other components of the immune system. T[ 11 cell enhance the 
microbial properties of macrophages. Meanwhile, T||2 are noted in aiding B ccll 
activation; B ccll activation by TM2 is mediated through CD40 interaction with CD40 
ligand (CD40L), which results in cytokine production by the Tn2 cell to activate the B 
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cell (Abbas et al., 1996, Bromley et al., 2001, Kapsenberg, 2003, Murphy et al., 2008, 
von Andrian & Mempcl, 2003). 
CD4* T cells also have an impact on the induction of antigen specific CD8* T cell 
or cytotoxic T lymphocyte (CTL) responses in the LN. CTLs are critical to fighting 
intracellular pathogens as they recognize viral peptides displayed by infected cells on 
MHC class I complexes and subsequently kill the infected cells. Cell death is achieved 
through the release of cytotoxic granules containing perforin, granyzme, and granulysin 
(Murphy et al., 2008, Barry & Blcackley, 2002). Notably, the ability to produce 
granzyme, as well as the expression of CD69 can be used for evaluation of CTL effector 
responses (Kumamoto et al., 2011). The production of active CTLs is also another 
instance in which CD4 influence/interaction with DCs is critical; within the LN, CD4f T 
cells aid CTL responses in multiple ways including licensing of dendritic cells (DCs) for 
efficient antigen presentation as DCs activated by CD4+ T cells are able to more 
efficiently prime cognatc CD8f T cells through the expression of CD25, the alpha chain 
of the interlcukin 2 (IL-2) receptor which increases binding of affinity of IL-2 which 
drives T cell proliferation, and CD 127, the intcrleukin 7 receptor which plays a role in 
maintaining secondary responses. Furthermore, antigen specific CD4' T cells facilitate 
the recruitment of naive CD8' T cell via secretion of CCL3 and CCL4, thereby 
increasing the efficiency of producing memory CTLs (Bchrcn et al., 2004, Castellino & 
Germain, 2006, Murphy et al, 2008, Smith et al, 2004). In the instance of HSV-2 
infection, CTL responses are robust (Kolle et al., 1998) and CD4f T cells are required for 
the generation of both primary and secondary CTLs (Janssen et al., 2003, Kumamoto et 
al, 2011, Rajasagi et al., 2009). 
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The link between arteriole remodeling and adaptive immunity on-set (Soderberg el 
a/., 2005) speaks to the great importance of determining the mechanism of remodeling, 
and all of the major points noted above support the investigation of CD4' T cells as a 
driving force in LN arteriole remodeling. To this end, experiments detailed below dissect 
the role of CD4+ T cells in LN arteriole remodeling following HSV-2 infection, and 
demonstrate it to be CD4* T cells dependent. Furthemiorc, in combination with excellent 
work by collaborators in Dr. Iwasaki's lab at Yale University the conclusion that arteriole 
remodeling dependence on CD4f T cells is driven by CD4 T cell interaction with DCs 
through MHC II to TCR and through CD40 and CD40L interface is drawn and Dr. 
Iwasaki's groups further shows that this was a critical factor in facilitating naive 
polyclonal CD8+ T cells entry into the LN, which resulted in decreased magnitude of 
CTL response to infectious agent (Kumamoto et ai, 2011) and identifies CD4+ T cell 
driven vascular growth of the LN feed arteriole as a mediator of CTL responses. 
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4.2 Results 
To determine if CD4f T cell were required for lymph node arteriole remodeling, 
LN feed arterioles in mice deficient in CD4* T cells due to genetic ablation (CD4 " mice), 
which have not previously been noted to have defects in LN vasculature, following 
infection with Tk"HSV-2 were examined. Arterioles in these mice showed no significant 
difference in resting vessel diameter at one, three or seven days after infection when 
compared to day zero controls (Figure 7A). The extent to which remodeling is inhibited 
is most blatant when comparing arterioles from day zero p.i. and day seven p.i. in CD4"" 
mice to each other as well as to an arteriole from a day seven p.i. WT C57 BL/6 mouse, 
which is notably larger on gross examination (Figure 7B), as well as when comparing the 
increase in resting diameter at days three and seven p.i. relative to the mean diameter at 
day zero p.i. (Figure 7C). This data indicates that CD4' T cells are required to regulate a 
change in resting LN arteriole set-point during induction of adaptive immune response as 
in the absence of CD41 T cells there is no notable increase in resting arteriole diameter 
following infection as is seen in wild-type mice. 
As the mechanism governing resting arteriole tone and therefore set-point, may be 
different than that governing remodeling and maximal vessel diameter, maximal vessel 
diameter was also examined. Similar to resting vessel diameter, maximal vessel diameter 
remained unchanged at days zero, three, and seven p.i. in comparison to day zero 
controls. Day zero controls had an average maximal vessel diameter of 144^im in 
comparison to average diameters of 142, 131, and 129(.im at days one, three, and seven 
p.i. respectively (Figure 8A). This lack of LN arteriole remodeling is in distinct contrast 
to maximal vessel remodeling observed in day seven p.i. WT arterioles (Figure 8B) and is 
62 
characterized by significantly decreased levels of arteriole expansion, relative to 
uninfected day zero controls, when compared to WT mice (Figure 8C). Given that WT 
mice were infected throughout the course of the study and consistently demonstrated LN 
arteriole remodeling and CDC" mice showed characteristic signs of infection including 
redness and lesions around the infection site which indicates successful infection, these 
findings show that CD4* T cells are required for expansion of the draining lymph node 
feed arteriole throughout the course of infection. 
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Figure 7: CD4" * Lymph Node Arteriole Resting Vascular Profile Throughout 
Infection. A. Resting arteriole diameter at days zero, one, three, and seven 
after i.vag. infection with TK'HSV-2 of CD4~ mice. B. Representative images 
of resting diameter arterioles following infection at days zero, and seven after 
infection from CD4"" mice in comparison to maximal remodeling noted at day 
seven in C57 BL/6 (WT) mice. In each image a green arrow indicates the 
arteriole. C. Resting vessel size at day one, three, and seven p.i. relative to 
mean day zero p.i. diameter expressed as a percent change for WT and CD4"" 
mice. Data represents mean diameter (A) or percentage of day zero diameter 
(C) ± SEM wherein n^-4 for day zero and n-5 for each of day one, three, and 
seven in CD4 ~ mice and n=l 1, 6, and 5 for WT mice at days zero, three, and 
seven p.i. respectively with one arteriole studied per animal. *p<0.05, 
**p<0.01, and ***p<0.001. 
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Figure 8: CD4"" Lymph Node Arteriole Maximal Diameter Vascular Profile 
Throughout Infection. A. Maximal arteriole diameter at days zero, one, three, 
and seven after i.vag. infection with TK'HSV-2 of CD4 mice. Maximal vessel 
diameters were recorded after superfusion of 100[iM SNP. B. Representative 
images of maximal diameter arterioles following infection at days zero, and 
seven after infection from CD4"" mice in comparison to maximal remodeling 
noted at day seven in C57 BL/6 (WT) mice. In each image a green arrow 
indicates the arteriole. C. Maximal vessel size at day one, three, and seven p.i. 
relative to mean day zero p.i. diameter expressed as a percent change for WT 
and CD4 " mice. Data represents mean diameter (A) or percentage of day zero 
diameter (C) ± SEM wherein n=4 for day zero and n=5 for each of day one, 
three, and seven in CD4"" mice and n-11, 6, and 5 for WT mice at days zero, 
three, and seven p.i. respectively with one arteriole studied per animal. 
*p<0.05, **p<0.01, and ***p<0.001 
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In addition to determining resting and maximal vessel diameters, vasoconstriction 
in response to phenylephrine was evaluated to assess preparation health as well as any 
change in smooth muscle function that may result from the absencc of CD4' T cells 
(Figure 9A) as CD41 T cells have been shown to induce increased smooth muscle density 
in pulmonary arterioles (Delay et al., 2008) and induce vascular damage (Burne et al., 
2001, Cuttica et al., 2010). Furthermore, cross sectioning and H&E staining of LN 
arterioles were obtained (Figure 9B). CD4"" arterioles at all days following infection, 
including day zero controls, showed constriction in response to phenylephrine similar to 
that seen in WT controls and H&E staining showed no change in arteriole morphology 
compared to WT controls as well as consistent morphology throughout the course of 
infection. 
Next, the potential to inhibit remodeling pharmacologically by using mice depleted 
of CD4f T cells via antibody treatment was explored. Mice depleted of CD4+ T cells 
showed no increase in resting or maximal vessel diameter three or seven days post-
immunization (Figure 10A, B) with response to phenylephrine consistent to that seen in 
WT mice (Figure 10C). Notably, while day zero controls were given antibody and a 
separate set of vehicle (sterile PBS) treated mice were not tested, this is a well established 
model in Dr. hvasaki's lab and depleted mice at day zero p.i. had similar resting and 
maximal arteriole diameters to WT mice (Figure 10D). Together, these results show that 
pharmacological inhibition of arteriole remodeling is possible through antibody depletion 
of CD41 T cells and support conclusions from CD4 * mice that LN arteriole remodeling 
during infection is dependent upon CD4 T cells. 
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As the requirement for CD4* T cells was supported in both genetic ablation and 
pharmacological inhibition, experiments subsequently aimed to determine if CD4' T cclls 
were required within the lymph node or were capable of supporting arteriole expansion 
from the periphery. To test this, arteriole remodeling in L-scIectiiVa key selectin in 
naive CD4" T cell migration to LNs during infection (Finger et a/., 1996), was explored. 
Preliminary vessel size data and images are shown and suggests that genetic ablation of 
L-selectin inhibits lymph node arteriole remodeling (Figure 11A, B), which would 
indicate that the requirement for CD4* T cells in the LN arteriole expansion is in the LN 
itself and CD4f T cclls in the periphery are not sufficient to drive remodeling. However, 
unfortunately, an inability to access more L-selectin"" mice prevented completion of this 
data set. 
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Figure 9: CD4" " Arteriole Phenylephrine Response and H&E Staining of Node 
Arteriole Sections During Infection. LN arterioles treated with lOOuM SNP 
and isolated from anesthetized mice and then fixed in 10% buffered formalin 
and then embedded in paraffin. Sections were H&E stained and imaged at 400x 
using a standard light microscope. Representative images are shown for A. day 
zero p.i. B. day seven p.i.. 
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Figure 10: Arteriole Remodeling in CD4+ T Cell Depleted Mice. A. Resting arteriole 
diameter zero, three, and seven days after i.vag. infection in CD4 depleted 
mice. B. Maximal arteriole diameter (+100^M SNP) zero, three, and seven 
days after i.vag. infection. C. LN arteriole phenylephrine (PE) dose response 
from 10"9M to lCT^M at zero, three, and seven days post-infection. D. Resting 
and maximal diameters of WT mice and CD4 depleted mice at day zero. Data 
represents mean diameter (A, B, D) and mean vessel constriction (C) ± SEM. 
*p<0.05, **p<0.0l, ***p<0.001, ns=-no significant difference. N=3, 5, and 4 
for days zero, three, and seven p.i. respectively in CD4 depleted mice and 
n = 11 for WT mice at day zero p.i. with one arteriole studied per animal. 
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Figure 11: Arteriole Remodeling in L-selectin" " Mice. A. Resting and maximal vessel 
diameters in L-selectin"" at days at zero and seven days following infection 
with Tk"HSV-2. B. Representative images of resting L-selectin"" lymph node 
feed arterioles at days zero and seven p.i.. where n=l for all points. 
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Given the dependence of LN arteriole remodeling on the presence of CD4* T cells, 
disease processes that decreased circulating levels of CD4 T cells may also inhibit 
arteriole remodeling. To explore this possibility, arteriole remodeling in aged mice was 
looked at because aging of the immune system is characterized by a decrease in the 
number of circulating naive CD4' T cells. Interestingly, aged mice showed no increase in 
resting or maximal vessel diameter seven days p.i. when compared to day zero controls 
(Figure 12A). Additionally, comparing the relative increase in resting and maximal vessel 
diameter at day seven clearly demonstrates lymph node arteriole remodeling is 
significantly inhibited in aged micc, which had an average age of 22 months, in 
comparison to adult micc, which ranged from 8 to 20 weeks of age (Figure 12B). Finally, 
although old mice at day zero p.i., had phenylephrine response curves similar to adult 
mice, response to PE were consistently and significantly blunted at 10~6M and 10"5M 
concentrations seven days following infection (Figure 12C), indicating a change in 
arteriole physiology during infection in aged mice that is not seen in adults. 
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Figure 12: Arteriole Remodeling in Old Mice. A. Resting and maximal (+100|xM SNP) 
arteriole diameter zero and seven days after i.vag. infection in aged mice 
(average age= 22 months) where n=4 for day zero and n=6 for day seven. B. 
Vessel size at day seven p.i. relative to uninfected day zero mice in adult and 
old mice. Comparison is expressed as a percent increase over day zero 
controls to normalize for increased arteriole size seen in larger, older mice. C. 
Phenylephrine (PE) dose response (percent vessel constriction) from 10~9M to 
10°M at zero and seven days p.i.in old mice where n=-4 and 6 rcspecitvely in 
comparison to days zero and seven in adult mice where n=6 and 5 
respectively. Data represents mean diameter (A), mean diameter expressed as 
a percentage of day zero controls (B), and mean vessel constriction (C) ± 
SEM where one arteriole was studied per mouse. *p<0.05, **p<0.01, 
***p<0.001. 
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4.3 Discussion 
Here, the first step in determining the mechanism of LN feed arteriole remodeling 
is provided by demonstrating that the process is CD41 T cell dependent, which represents 
a notable step forward in the current understanding of LN vascular regulation. 
Interestingly, CD4 mice had larger diameter LN arterioles than wild-type mice in the 
uninfected state, indicating that CD44 T cells may play a role in not only regulating LN 
vasculature during infection, but also during homeostasis. This suggests that CD4* T cells 
may play a role in regulating the steady-state (Kumamoto et ai, 2011). Despite this 
difference in wild-type and CD4"' vessel size, the conclusion that CD4* T cells are 
required for LN arteriole remodeling is confirmed by studies showing inhibition of 
remodeling in wild-type (C57 BL/6) mice depleted of CD4+ T cells, becausc it 
demonstrates the inhibitory effect of loss of CD4f T cells in a strain in which LN arteriole 
remodeling is known to be robust. Furthermore, initial results from L-selectin "mice 
support the need for CD4+ T cells, and that such requirement occurs within the LN, as L-
selectin is required for trafficking into the LN and loss of L-selectin would prevent entry 
of CD4" T cells into the LN (Bradley et al., 1994, Murphy et ai, 2008). 
In considering studies that suggest mechanisms of vascular growth in the LN that 
would potentially be applicable to remodeling of LN arteriole, those demonstrating 
VEGF and DCs as key LN vascular growth regulators stand out (Chyou et al., 2008, 
Webster et ai, 2006, Shrestha et ai, 2010), and leads to proposing that DCs and VEGF 
drive expansion of the LN arteriole. Below is an analysis of how results presented in this 
study support a role for DCs in CD4" T cell dependent LN arteriole remodeling. 
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However, direct evidence of a role for VEGF requires further study and is discussed as a 
future direction. 
DCs within the reactivc LN are optimally positioned to act on upstream HEVs and 
vasculature as they wrap themselves around HEVs to scrccn lymphocytes entering the 
LN and have significant interaction with CD41 T cells (Bajenoff, et al., 2003, Murphy et 
al., 2008) and may transmit signals to the upstream vasculature. Furthermore, the 
depletion of DCs results in decreased lymph node hypertrophy and EC proliferation, both 
of which correspond to the timeline of arteriole remodeling. The degree of EC 
proliferation within stimulated LN has also been shown to correspond proportionally to 
the number of DCs in the LN (Webster et al., 2006). This may also explain the 
relationship of B cells to LN vascular growth as B cells, via VEGF driven 
lymphangiogenesis, were recently shown to enhance DC migration to the lymph node 
(Angell et al., 2006, Shrcstha et al., 2010); B cells may be facilitating vascular growth via 
enhancing DC migration, which subsequently drives other forms of vascular growth such 
as HEVs and feed arteriole expansion. However, studies by collaborators provide 
evidence against this, as mice lacking B cells had no deficit in LN enlargement and loss 
of CD4+ T cells resulted in decreased B cell recruitment into the node. One potential 
explanation for these conflicting reports may be an intermediate step between B cells and 
DCs. As B cells, and related VEGF expression, have been linked to the expression of 
LTpR, we propose that LT^, produced by the FRC as previous demonstrated (Browning 
et al., 2005, Chyou et al., 2008, Kumar et al., 2010) or alternatively, produced by or 
controlled by DCs in a CD4' T cell dependent manner may be such an intermediate. 
While this hypothesis remains to be investigated, LN enlargement was found to be 
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dependent upon CD4' T cell interaction with DCs through MHC II to ICR and through 
CD40 and CD40L interface. Dr. Iwasaki's groups further showed that this was a critical 
factor in facilitating naive polyclonal CDS* T cells entry into the LN, which resulted in 
decreased magnitude of CTL response to infectious agent (Kumamoto et al., 2011). 
Collectively, these results, in combination with our own, identifies CD4+ T cell driven 
vascular growth, of the LN feed arteriole, through DC interaction, as a mediator of CTL 
responses to intracellular pathogens. Alternatively, despite strong evidence for DCs in 
LN vascular growth and the interaction of CD4 T cells with DCs, which regulates 
cellular entry into the LN and LN enlargement, another possibility is that antigen-specific 
CD4* T cells are also acting independently to induce the recruitment of naive CD4f T 
cells and induction of subsequent arteriole remodeling (Kumamoto et al., 2011). This 
mechanism could be potentially driven by the production of interferon gamma, which has 
been shown to enhance migration into the LN (Hendriks et al., 1989, Kraal et al., 1994). 
The absence of remodeling seen in old mice also supports the importance of CD4+ 
T cells in arteriole remodeling, as aged mice show decreased CD4' T cell numbers, 
decreased proliferation of antigen specific CD4f T cells, and a marked dcclinc in ability 
to mount effective adaptive immune responses (Linton et al., 2004). However, further 
experiments are needed to reveal changes in the aged LN in response to HSV infection to 
conclude whether low numbers or functionality of CD4 T cells are responsible for 
defects in remodeling seen in aged mice as other alternatives arc plausible. One such 
alterative reason for lack of arteriole remodeling may be the result of vascular 
dysfunction during infection seen with aging indicated by the decrease in arteriole 
responsiveness to phenylephrine. What was most surprising about this observation was 
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that the blunted response was only seen at day seven after infection and not at day zero. 
Had a blunted response been observed in all old mice, regardless of days p.i., this would 
be indicative of the aging disease process had a pathogenic effect on the feed arteriole. 
However, as the blunted response is only seen during infection, which is not seen in adult 
mice, this suggests that the infection is causing pathology within the vessel that changes 
responsiveness to the action of the «i-adrenergic receptor agonist on the smooth muscle 
cells of the arteriole. Why this is seen during infection of old mice and not young remains 
unclear and has not previously been noted in the literature. However, a greater 
understanding of vascular dysfunction resulting during infection with aging would 
provide further insight into decreasing immunity and vascular dysfunction during aging. 
Even though findings within this chapter generate a number of new future 
directions and research questions, the overall goal is fulfilled as the first steps within 
determining the mechanism of arteriole remodeling were taken. Arteriole remodeling is 
shown to be a CD4f T cell dependent process through interaction with DCs within the 
LN and links to priming of CTL that are vital for pathogen clearance. These findings also 
agree with previous studies of the integral nature of VEGF and DCs in the LN and 
highlight the need for continued study of LN arteriole remodeling and speak to the 
therapeutic potential in learning to manipulate immune response through altering of the 
LN microvasculature. For example, it could be used to boost immune response, by 
facilitating faster and/or increased entry into lymph nodes which would serve to decrease 
the rate limiting process of screening for cognate lymphopcytes and priming of CTLs. 
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CHAPTER FIVE - Vascular Mediators in Lymph Node Arteriole Remodeling 
5.1 Introduction 
During infection, lymph nodes (LNs) serve as an interface between the innate and 
adaptive immune system and are the site of induction of antigen specific cytotoxic T 
lymphocyte (CTL) responses that are critical to fighting intracellular pathogens. In 
previous chapters, the full spectrum and type of arteriole remodeling throughout the 
course of infection was elucidated and immune mediators were considered in the 
remodeling process as the magnitude and kinetics of remodeling mimicked previously 
noted changcs in LN vascularity driven by the immune system (Angcll et al., 2006, 
Chyou et al., 2008, Liao & Ruddle, 2006,Webster et al., 2006). This revealed arteriole 
remodeling to be dependent upon the presence of CD4+ T cells and driven by CD4r T cell 
interaction with DCs which was critical factor in facilitating naive polyclonal CD8+ T 
cells entry into the LN, which resulted in decreased magnitude of CTL response to 
infectious agent (Kumamoto et al., 2011). While this identifies CD4' T cell driven 
vascular growth of the LN feed arteriole as a mediator of CTL responses to intracellular 
pathogens, further study of the vascular changes that occur within the LN arteriole and 
the mechanism driving its expansion are critical components to understanding the 
potential therapeutic applications of using the LN arteriole to influence immune response. 
Having explored immune mediators, investigation of the other side of this immune-
vascular phenomenon, vascular mediators, was the next direction in exploring the 
mechanism of arteriole remodeling. Original reports of arteriole remodeling during 
infection showed a blunted degree of arteriole constriction with pharmacological 
inhibition of NOS three days following infection. This demonstrated a decrease in nitric 
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oxide mediated vasodilation as NOS is required for NO production, which acts on SMCs 
through guanylate cyclase to induce vasodilation (Soderbcrg et a/., 2005, Vanhoutte, 
2003). Despite this interesting observation, whether this state of decreased response to 
NOS inhibition mirrors the pattern of arteriole remodeling or is transient on specific days 
following infection remains to be determined. To address this, arteriole response to L-
NAME, which is a global inhibitor of NOS, was considered throughout the course of 
infection and subsequently revealed that blunted constrictive response to L-NAME is 
transient. 
Blunted response to NOS inhibition also suggests a role for NOS in mediating 
arteriole remodeling, and notably, NO is important in lymphocyte trafficking, which is a 
key component in arteriole remodeling (Kumanmoto et al., 2011), with NO noted as 
inhibitor of leukocytc adhesion to endothelium, and L-NAME treatment resulting in 
increased adherence and emigration (Akimitsu et al, 1995, Kubes, 1991). NO is also a 
mediator of ICAM-1 binding by leukocytes and a mediator of altered hemodynamics, 
which through impact on leukocyte distribution within vessels and activation of selcctins, 
including L-selcctin, and adhesion molecules impacts cellular trafficking (Alon & Dustin, 
2007, Finger et al., 1996, Kubes et al, 1991, McEver & Zhu, 2007, Ridger et al., 2008, 
Sucosky et al., 2009). Beyond its impact on immune cells, NO is a known regulator of 
VEGF induced vascular growth; mice deficient in cNOS do not respond to VEGF and 
subsequently have defective angiogenesis, arteriogencsis, and mural cell recruitment and 
increased levels of VEGF arc inducible through increased eNOS levels (Benest et al., 
2008, Yu et al, 2005). NO is also a regulator of EC proliferation, which is a key 
component of LN vascular growth mediated through VEGF and DCs (Metaxa et al, 
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2008, Webster et al., 2006). The later of which was linked to arteriole remodeling given 
the interaction DC interaction with CD4' T cells of which arteriole remodeling is 
dependent (Kumamoto et al., 2011). Therefore, given the role of NO in lymphocyte 
trafficking and VEGF and the key role of lymphocytes in arteriole remodeling, the 
hypothesis that eNOS was required for arteriole remodeling and LN hypertrophy was 
investigated using both pharmacological inhibition (systemic trcament with L-NAME) 
and genetic ablation models (eNOS"" mice). 
In addition to eNOS, a seconded vascular mediator, TNF-alpha was considered. 
TNF-alpha, like NO, is noted to play a role in leukocyte trafficking. In skeletal muscle, 
TNF-alpha recruits Tul cells (Norman et al., 2008) and in aging models of delayed 
hypersensitivity, memory CD4* T cells arc prevented from migrating due to a lack of 
TNF-alpha secretion (Agius et al., 2009). TNF-alpha has been shown to be an inducer of 
vascular remodeling acting through TNF receptors on vascular ECs during infection, as 
well as a mediator of angiogenesis in vivo, and an inducer of NOS during HSV infection 
(Baluk et al., 2009, Benecia, et al., 2003, Frater-Schrodcr et al., 1987, Leibovich et al., 
1987). Therefore, with the role of TNF-alpha in facilitating changes in NO levels, 
vascular remodeling, and dynamics of lymphocyte migration, the hypothesis that TNF-
alpha was required for arteriole remodeling became a study focus and investigated using 
TNF-alpha"" mice. 
Conclusions regarding the role of TNF-alpha in arteriole remodeling led to 
questions regarding the mechanism by which TNF-alpha acts on the LN and to 
investigation of the role of mast cells, as mast cells are large producers of TNF-alpha 
(Murphy et al., 2008). While mast cells have a well established function in innate 
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immune response, it is only recently that their important role in adaptive immunity has 
begun to be appreciated based on the collective findings of McLachlan and colleges 
(2008, 2003). Markedly, the dcgranluation of mast cells in the footpad (induced cither 
with intradermal bacterial challenge or mast cell activator compound 48/80) has been 
shown to induce cellular accumulation of naive T lymphocytes in the draining popliteal 
lymph node and hypertrophy of the dLN itself. This hypertrophy peaked twenty-four 
following stimulation and resolved by fourty-cight hours. Increased ccllularity and DC 
numbers characterized hypertrophy, with mast cell deficient mice showing reduced LN 
hypertrophy. Furthermore, these findings were attributable to the release of 
prcsynthesized TNF-alpha that drained into the LN from the footpad, with TNF protein 
levels increasing in the LN within one hour of stimulation (McLachlan et al., 2008, 
McLachlan et al., 2003). Such remote control of the LN has been shown in other cases; 
monocyte recruitment to the LN was upregulated by selective trafficking of MCP-1 for 
inflamed skin to the HEVs dLN as evidenced by IVM staining (Palframan et al, 2001). 
These findings lead to the hypothesis that activation of mast cells may facilitate 
remodeling of the dLN feed arteriole in the process of initiating adaptive immunity. 
Therefore, the role of mast cells was investigated using mast cell deficient mice in 
combination with gross examination of LN for evidence and hypertrophy and IVM to 
explore requirement for LN arteriole remodeling. 
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5.2 Results 
Based on the previously established importance of eNOS in regulating cell 
migration, vascular growth, endothelial ccll proliferation, and modulation of VEGF in 
other contexts (Bcnest et al., 2008, Chyou et al., 2008, Norman et al., 2008, Yu et a!., 
2005), the role of eNOS in arteriole remodeling was investigated. Genetic ablation of 
models lacking expression of eNOS showed an inability to remodel LN arterioles in 
response to infection (Figure 13A, B). Seven days following infection, the point at which 
maximal remodeling was seen in wild-type micc (Figure 3), eNOS " showed no increase 
in resting or maximal diameter. However, they still maintained robust response to 
phenylephrine (Figure 13C). 
To confirm ablation results and address any possibility that lack of remodeling was 
an artifact of genetic manipulation, we looked at LN arteriole remodeling capacity of 
wild-type mice treated systemically with NOS inhibitor L-NAME (Figure 13D). In 
accordance with eNOS"", pharmacological inhibition of NOS resulted in no significant 
change in arteriole diameter during infection. This clearly demonstrates the requirement 
for eNOS expression in facilitating LN arteriole remodeling and is underscored when 
comparing the percent increase in resting and maximal arteriole diameter relative to day 
zero diameters in WT, eNOS", and L-NAME treated mice at day seven p.i., (Figure 13E) 
which shows significantly blunted response when eNOS is ablated or NOS function is 
blocked. 
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Figure 13: eNOS is Required for Lymph Node Arteriole Remodeling During 
Infection. A. Resting and maximal (+nifcdapinc) arteriole diameter at days 
zero and seven p.i. in eNOS" mice with TK'HSV-2 B. Representative images 
of resting and maximal diameter eNOS" "arterioles at days zero and seven 
after infection where arterioles are indicated by green arrows. C. Percent 
vessel constriction with respect to resting vessel diameter of eNOS " LN 
arterioles at day zero and seven p.i. in response to PE applied in fold 
increases from 10"9 to 10'5M. D. Resting and maximal (+SNP) arteriole 
diameter at days zero and seven p.i. with Tk"HSV-2 in mice treated 
systemically with L-NAME. E. Resting and maximal vessel diameters (% of 
uninfected) of WT, eNOS" and L-NAME treated mice. For eNOS"" n=4 and 
5 respectively for days zero and seven vessel diameters, and n=4 for all PE 
data points. For L-NAME treatment, n=4 for all data points. For WT n=5 at 
day seven p.i.. In all cases, one arteriole was studied per animal. *p<0.05, 
**p<0.0l. and ***p<0.001. 
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The absence of such arteriole remodeling as a result of CD4' T cell deficiency was 
shown to result in decreased LN hypertrophy due to decreased cellular trafficking 
(Kumamoto et al., 2011). To examine whether eNOS deficiency had the same result, 
lymph node size and weight following infection was examined. This investigation 
reavealed that LNs from eNOS"" showed no increase in size throughout the course of 
infection (Figure 14A). Furthermore, weight of isolated eNOS" "lymph nodes were similar 
at days zero and seven following infection (Figure 14B), and demonstrates that eNOS is 
required for LN arteriole remodeling and subsequently lymph node hypertrophy. 
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Figure 14: eNOS is Required for Lymph Node Hypertrophy. A. Representative 
images of isolated eNOS"" lymph nodes at days zero, one, five, and seven p.i.. 
B. Lymph node weights of isolated eNOS"" lymph nodes following infection 
at days zero and seven p.i.. 
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Given the importance of eNOS for remodeling, initial reports that described blunted 
response to inhibition to NOS at day three p.i. was considered (Soderberg et al., 2005) as 
it remained unknown if this blunted response continued throughout the course of 
infection similar to remodeling of the arteriole. This was addressed by looking at vessel 
response to L-NAME perfusion over the intravital microscopy preparation of the feed 
arteriole of C57 BL/6 mice at days zero, one, three, five, seven, nine, and thirty-five p.i. 
(Figure 15A, B). Similar to previous findings, the arteriole showed blunted constriction to 
L-NAME three days p.i., however, this blunted response was not noted at day one p.i., 
but did persist through day five p.i. (Figure 15A). Notably, by day 7 p.i. response had 
returned to values similar seen at day zero p.i. and remained there through days nine and 
thirty-five p.i. (Figure 15B), and demonstrates a pattern of transient decrease in NOS 
activity during infection. 
As arteriole remodeling was dependent on CD4+ T cells, the question of whether 
the same mechanism was regulating NOS activity in the arteriole arose. To address this, 
the effect on L-NAME treatment on vessel diameter was studied in CD4" * mice at days 
zero, three, and seven p.i. (Figure 15C) and showed that in the absence of CD4' T cells, 
the arteriole still shows a blunted response to NOS inhibition at day three p.i., which 
returns to baseline levels by seven days p.i.. Collectively, these results demonstrate that 
the transient decrease in NOS activity seen in WT mice (Figure 15A, B) is not dependent 
upon CD4 T cells. 
93 
Figure 15: Nitric Oxide Levels are Variable During Infection and CD4 Independent. 
Percentage of vessel constriction in response to perfusion of IOOjaM L-
NAME solution over the vessel preparation A. Days zero, one, three, and five 
p.i. in C57 BL/6 mice. B. Days zero, seven, nine, and thirty-five p.i. in C57 
BL/6 mice C. zero, three, and seven days p.i. in CD4" "mice. Data represents 
percent vessel constriction in diameter ± SEM where one arteriole was 
studied per animal. *p<0.05 **p<0.01, and ***p<0.001. 
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Next, based on studies previous studies demonstrating TNF-alpha as a key 
regulator of LN hypertrophy and as mediator of vascular changes (Baluk et at2009, 
McLachlan et al., 2008, McLachlan et al., 2003), the ability of the LN feed arteriole to 
remodel in the absence of TNF-alpha was examined. Three and seven days p.i., mice 
deficient in TNF-alpha showed no increase in resting or maximal vessel size compared to 
day zero p.i. (Figure 16A, B), but still showed excellent response to PE that was 
comparable to wild-type day zero controls (Figure 17A). Additionally, H&E stained 
vessels showed no change in vessel morphology (Figure 17B). Furthermore, loss of TNF-
alpha did not change vessel response to L-NAME at days three and seven during 
infection; arteriole response to application of L-NAME at day zero in Tnf-alpha deficient 
mice was similar to wild-type mice, and a significant decrease in response is seen at day 
three p.i., which returns to normal levels by day seven p.i. (Figure 17C). Collectively, this 
data demonstrates that TNF-alpha is required for LN arteriole remodeling during 
infection, but does not mediate the transient drop in vessel response to NOS inhibition. 
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Figure 16: Role of TNF-alpha in Lymph Node Arteriole Diameter. A. Resting and 
maximal (+100|uM SNP) arteriole diameter zero, three, and seven days after 
i.vag. infection in TNFa"" mice with n= 5 for day zero and n=4 for days three 
and seven respectively. B. Representative image of resting arterioles with 
arterioles indicated by green arrows. Data represents mean diameter ± SEM 
(A), where one arteriole was studied per animal. *p<0.05, **p<0.01, 
***p<o 001, ns-= not significant. 
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Figure 17: Role of TNF-alpha in Lymph Node Arteriole Vasoactive Profile During 
Infection. A. Phenylephrine (PE) dose response (percent vessel constriction) 
from 10"9M to lO^M at zero (n=5), three (n=4), and seven (n=4) days p.i. in 
TNFa"" mice in comparison to WT C57 BL/6 mice (n=5) B. Representative 
images of H&E stained arteriole cross-sections in TNFcx"" mice zero and 
seven days p.i.. C. Percentage of vessel constriction in TNFa" " mice in 
response to perfusion of 100,uM L-NAME at days zero (n=5), three (n=4), 
and seven (n=4) following infection. Data represents mean vessel constriction 
(A, C) ± SEM where one arteriole was studied per animal. *p<0.05, 
**p<0.01, and ***p<0,001. 
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Reports that cited TNF-alpha as a mediator of LN expansion provided evidence that 
the key source of TNF-alpha was mast cells; significant levels of mast cell degranulation 
is noted within two hours of challenge and mice given TNF-alpha-deficient mast cells 
have blunted LN hypertrophy (McLachlan et a/., 2008, McLachlan et ai, 2003). This, in 
combination with the requirement for TNF-alpha demonstrated above, prompted 
investigation of the requirement for mast cells in arteriole remodeling. Mice deficient in 
mast cells showed significant remodeling seven days p.i., in comparison to day zero 
controls (Figure 18A). However, vessels were still significantly smaller than day seven 
wild-type mice (Figure 18B). Furthermore, mast cell deficient mice demonstrated a 
moderate level of LN hypertrophy (Figure 18C). Collectively, this suggests that arteriole 
remodeling is partially dependent upon mast cells and that mast cells contribute to the 
magnitude of arteriole remodeling. 
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Figure 18: Role of Mast Cell in Lymph Node Arteriole Remodeling. A. Resting and 
maximal (+30|^M Nifcdapinc) arteriole diameter at zero (n-4) and seven 
(n=5) days after i.vag. infection in mast cell deficient mice B. Comparison of 
maximal arteriole diameter in wild-type (C57 BL/6) (n^5) and mast cell 
deficient mice (n-^5) at day seven following infection C. Representative 
images of lymph nodes from mast cell deficient mice at days zero and seven 
following infection. Data represents mean vessel diameter (A, B) ± SEM 
where one arteriole was studied per animal. *p<0.05, **p<0.01, and 
***p<0.001. 
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5.3 Discussion 
Presented here are the first studies to implicate NO in the regulation of lymph node 
expansion, as the role of NO in the vasculature of the LN and its subsequent impact on 
immune response has never been studied outside of our initial report (Sodcrbcrg et al., 
2005). Results, using both genetic and pharmacological means, show that the mechanism 
of arteriole remodeling is eNOS dependent and that constriction as a result of L-NAME 
perfusion over the arteriole is decreased three and five days p.i.. Blunted response to 
NOS inhibition three and five days p.i., implies a change in NOS activity and 
subsequently NO production on these days. Alternatively, it could imply a change in NO 
bioavailability and NO acting upon the vessel and influencing diameter. Interestingly, 
this process was not dependent on CD4+T cells as arteriole remodeling was noted to be. 
Together, these data suggest that during infection the LN feed arteriole has decreased 
NOS activity contributing to vessel dilation three and five days p.i. and that this 
reduction, unlike the mechanism of remodeling, is not dependent upon CD4' T cells. 
This, in turn, leads to the conclusion that the mechanism governing NOS activity within 
the LN feed arteriole during infection is different than that regulating vessel remodeling 
and leaves the mechanism of blunted response to NOS inhibition as a future direction. 
While the mechanism of the blunted response to NOS inhibition remains to be 
elucidated, so docs its function. One hypothesis about potential function is to facilitate 
migration into the lymph node, which is supported by the lack of hypertrophy seen in 
eNOS"" LNs following infection. Additionally, previous studies have shown NO to 
inhibit T cell rolling along the endothelium, with inhibition of NOS leading to increased 
r o l l i n g ,  a d h e s i o n ,  a n d  e m i g r a t i o n  ( A k i m i t s u  e t a l ,  1 9 9 5 ,  K u b e s  e t a i ,  1 9 9 1 ,  S u n d r a n i  e t  
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al., 2000), therefore, the arteriole may facilitate T cell rolling by down-regulating NO 
production. However, complete shut-down of NO would be detrimental, as evidenced by 
the lack of LN hypertrophy in eNOS " mice and with pharmacological inhibition of NOS 
with L-NAMF. treatment. Lack of eNOS may be inhibitory to LN arteriole remodeling 
due to its impact on VEGF, which is key in LN vascular growth and EC proliferation 
(Webster et al., 2006). eNOS has been shown previously to be required for a response to 
VEGF outside the LN. In ischcmic conditions, loss of cNOS results in reduction in 
angiogenesis, arteriogenesis and mural cell recruitment (Murohara et al., 1998, Yu et al., 
2005) and exogenous delivery of eNOS has been shown to increase VEGF expression 
and give rise to mature phenotype of newly formed arterioles and capillaries (Benest et 
al., 2008). Alternatively, change in shear stress triggering EC proliferation in response to 
high flow, which would be required for increased delivery of blood to the LN and 
outward eutrophic remodeling, may also be a mechanism behind the requirement of 
cNOS dependency in the LN (Metaxa et al., 2008). 
It is also arguable that the blunted response to L-NAME, suggesting decreased NO, 
is contradictory to increases in VEGF that was previously proposed to be an player in 
arteriole remodeling and is key in LN ECs proliferation during infection (Webster et al., 
2006). This is because VEGF is known to activate eNOS. Following stimulation of 
VEGF receptors, increased eNOS expression results from activation of the PI3K7Akt 
pathways leading to release of eNOS from cavcolin-1, which binds eNOS and decreases 
its activity, with subsequent increased cNOS activity due to phosporylation (Fontana et 
al., 2002, Papapetropoulos et al., 1997). This means that decreased eNOS would be 
associated with decreased VEGF, both of which arc contradictory to vascular growth. 
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However, a theory of two separate pathways may harmonize these opposing points. The 
first pathway being that VEGF levels are unregulated in LN to facilitate vascular growth 
and that VEGF is secreted and/or signaling is directed upstream to the HEVs and 
subsequently the arteriole. The second pathway, that decreased NO induced vasodilation 
at days three and five p.i. are specific to the arteriole and arc not affcct by VEGF levels in 
the LN, but may play a role in supporting VEGF secretion by increasing lymphocyte 
trafficking. This is further supported by findings that while CD4f T cells and TNF-alpha 
were both required for LN arteriole remodeling, but the observed transient decrease in 
NO was not. 
The second part of investigation of vascular mediators of LN arteriole expansion 
focused on TNF-alpha, and demonstrated the proccss to be TNF-alpha dependent. TNF-
alpha is a known regulator of vascular remodeling, EC proliferation, and T cell migration 
but is known to act early in the process of vascular remodeling. This suggests that TNF-
alpha may act early in the LN arteriole remodeling process to induce initial stages of EC 
proliferation and T cell migration. Notably, in the case of M. pulmonis infection, increase 
in TNF-alpha preceded vascular remodeling events and blockade of TNF-alpha resulted 
in decreased VEGF levels, and leukocyte trafficking and slowed the process of 
remodeling of blood vessels (Baluk et ul., 2009), suggesting that TNF in the LN may be 
required for increased VEGF. TNF-alpha may also be facilitating VEGF expression and 
subsequent vascular expansion by facilitating DC migration into the LN (Baluk et ul., 
2009, Frater-Schrodcr et ol., 1987, Leibovich et al., 1987). Later in the arteriole 
remodeling and infectious process, TNF-alpha may also be acting to limit the magnitude 
of the inflammatory response within the LN. TNF-alpha been shown to up regulate the 
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A2b receptor, a receptor for CD73-generated adenosine known to be expressed on HEVs, 
and the absence of CD73 results in increased trafficking into the LN and vascular 
permeability, which is abrogated by pharmacological blockade of the A;b receptor. These 
findings suggest that CD73-gencratcd adenosine may act to limit inflammatory associated 
permeability within the LN, facilitated by TNF-alpha regulation of the A2B receptor 
(Tackedachi et a!., 2008). 
Studies on the requirement of mast cells for arteriole remodeling showed a partial 
requirement for mast cells; mice deficient in mast cells showed a decreased magnitude of 
remodeling. Previously, McLachlan and colleges (2003, 2008), showed that TNF-alpha 
released from mast cells was transmitted upstream to the LN and facilitated LN 
hypertrophy, including DC and lymphocyte accumulation. This would suggest that if 
arteriole remodeling was observed to be dependent on lymphocyte accumulation and 
interaction with DCs and TNF-alpha, it should also be dependent on mast cells. However, 
this cellular accumulation was transient, in studies by McLachlan and colleges cellular 
accumulation happened early, spiking at twenty-four hours and declining by fourty-eight 
hours, indicating requirement for TNF-alpha derived from mast cells acts early in the 
remodeling process, and that TNF-alpha derived from an alternative sources may act 
throughout the remainder of the remodeling process, although mast cell derived TNF-
alpha may facilitate increased magnitude of response, subsequently suggesting that this 
may be used in the future to increase the magnitude of arteriole remodeling and, 
therefore, the rate of screening for cognate lymphocytes. 
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CHAPTER SIX - CONCLUDING REMARKS 
6.1 Conclusions 
Historically, microcirculation and immunity appear to be mutually exclusive 
physiological components. However, beyond it's traditional role of nutrient, oxygen, and 
waste exchange, the microcirculation plays a varied and key role in immune functions. 
These functions range from the circulation and trafficking of immune cells specific to 
both inflammation and innate and adaptive immune response to invading pathogens, to 
expression of immune modulating cytokine and chemokines, and supply of metabolites. 
Therefore, the evaluation of the interface of microcirculation and immune function 
represents an interdisciplinary approach to gain new perspectives and insight into 
vascular physiology, immune function, and therapeutic avenues capable of influencing 
immune response and combating infection. Lymph nodes present themselves as a 
particularly noteworthy site to study microvascular-immune interface because they arc 
highly vascularized and are the site of induction of adaptive immune response required 
for antigen specific responses to infiltrating pathogens (Murphy et al., 2008). 
In the LN, adaptive immune response generated through antigen presentation of 
DCs in search of cognate naive lymphocytes in order to induce clonal expansion and 
proliferation giving rise of effector responses. During this induction of adaptive response, 
hypertrophy and increased ccllularity are notable and resolve following on-set of immune 
response (Soderberg et al., 2005, Murphy et at., 2008). Colligation of studies regarding 
LN vascularity reveal a large number of studies dealing with HEVs and older studies on 
general increases in blood flow to the LN during immune response. It also becomes 
apparent that there is relatively little known about the upstream regulation of blood flow 
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to the LN within the vasculature. In fact, the only study to do so first identified the 
phenomenon of remodeling of the LN arteriole and demonstrated its importance in 
facilitating delivery of naive lymphocytes into the LN and increasing the screening rate 
for antigen specific T cells. As this is the rate-limiting step in induction of adaptive 
immune response, arteriole remodeling was singled out as a novel factor in immune 
regulation (Soderberg et al., 2005). Therefore, in order to understand the phenomenon of 
LN arteriole remodeling during infection and begin to appreciate its significance, the 
following objectives were set forth: 
(i) To elucidate the extent and nature of vascular remodeling within draining 
lymph nodes during infection upstream of HEVs at the arteriolar level and 
consider the potential impact of such remodeling on health and disease. 
(ii) Begin to elucidate the mechanism of draining lymph node vascular 
remodeling in order to identify future targets for control of LN vascular 
supply. 
The data provided in the preceding chapters successfully fulfills these objectives by 
providing the complete timeline and magnitude of arteriole remodeling, demonstrating 
the outward cutrophic nature of the remodeling and identifying CD4* T cells, TNF-alpha, 
eNOS, and mast cells as key players. Below, findings of this study arc highlighted and a 
working hypothesis on the mechanism of remodeling is suggested. Furthermore, future 
directions that will help to refine and add to this working model arc proposed. 
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Timeline and Magnitude of Arteriole Remodeling 
The first course of action in further investigating arteriole remodeling was to 
determine the kinetics and magnitude of remodeling throughout infection. This revealed 
that arteriole diameter becomes significantly larger, in both the resting and maximal 
diameters states, as early as one day following infection. Subsequently, diameters 
continue to increase until a peak is reached seven days following infection. By day nine, 
arteriole diameter has already begun to significantly decrease from the noted peak, and 
diameters return to baseline by five weeks following infection (Figure 19). 
In correlating this to the timeline of infection, a rapid increase occurs during the 
first day following infection during innate responses is seen. Subsequently, arteriole 
diameter continues to increase steadily until day seven in correlation with the cellular 
accumulation with the dLN (Soderberg et a!., 2005). Following induction of adaptive 
response, CTLs begin migrating to the vaginal mucosal infection site between day three 
and five following HSV-2 infection (Nakinishi et al., 2009), arteriole diameter begins to 
fall and continues to decrease corresponding to the clearance of infection. This also 
supports the hypothesis of Hobbs and Hay of hyperemia in the first twenty-four hours 
followed by vascular growth as we see a rapid increase from day zero to one p.i. and 
continued increase from day one through seven p.i., but at a more modest rate. 
Furthermore, hyperemia would involve vasodilation, a point which is supported by that 
fact that if you integrate the areas under the cure of both the maximal and resting vessel 
diameters (Figure 19) or compare the percentage increase in comparison to day zero, 
there a larger change in resting vessel diameter than maximal diameter. Additionally, 
correlation of LN arteriole remodeling is not exclusive to the dynamics of the immune 
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system. It also generally correlates to changes in vasculature within the LN including 
HEV diameter and number, EC proliferation, and changes in blood flow (Hay & Hobbs, 
1977, Mebius el al., 1990, Myking, 1980, Soderberg et al., 2005, Webster et al.. 2006). 
I l l  
Figure 19: Time-course and Magnitude of Arteriole Remodeling Correlation to the 
Course of Infection. Following initial viral infection (day zero) a sharp 
increase in resting and maximal LN arterioles diameters is observed during 
the initial steps of adaptive immunity on the way to induction of adaptive 
response. Over the course of the next six days arteriole diameter continues to 
increase during the adaptive response induction and spikes at day seven. 
Following the induction of adaptive response and subsequent clearance of 
infection, arteriole diameters return to baseline. 
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Mechanism of Remodeling 
Throughout the preceding chapters we have identified CD4f T cells, TNF-alpha, 
eNOS, and mast cells as key players in LN arteriole remodeling during infection. Based 
on collaborative work, we also implicate this phenomenon in C'TL priming through CD4' 
T cell interaction with DCs (Kumamoto el al., 2011). When correlating these findings 
with other studies of vascular growth within the LN, changcs in HEVs, and the 
documented role of vascular mediators in vascular growth, we proposed a number of 
theories on the various parts of the mechanism governing arteriole remodeling. Figure 20 
below summarizes these hypotheses to give an overall depiction of a proposed 
mechanism of LN arteriole remodeling. 
First, during the initial stage of remodeling nitric oxide and TNF-alpha facilitate an 
initial stage of hyperemia and induce the beginning stages of endothelial cell 
proliferation. TNF-alpha, predominantly derived from mast cells, also serves to promote 
lymphocyte and dendritic cell migration into the lymph node. Once in the lymph node 
DC mediate an increase in VEGF that acts to induce further EC proliferation and vascular 
growth in a CD4f T cell dependent manner. Further into the course of infection, 
decreased NO levels and an ever expanding arteriole facilitate increased CD4! T cell 
migration. Additionally, arteriole expansion and CD41 T cells facilitate B cell migration 
into the lymph node, which may also contribute to VEGF production and subsequent 
vascular growth (Figure 20). 
114  
Figure 20: Proposed Mechanism of Arteriole Remodeling. 
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6.2 Future Directions 
While the figures above (Figure 19 and 20) provide a summary of the study 
findings and propose a mechanism of arteriole remodeling, and in doing so fulfill the 
proposed goals of the project, completion of number of future directions would be helpful 
confirming or ruling out some of the proposed parts of the mechanism. First, to address 
EC proliferation within the LN arteriole, experiments staining for BrdU incorporation 
into the arteriole as an indicator of cell division within the vessel as multiple time-points 
p.i. arc planned. Furthermore, evaluation of hyperemia and changes in vascular leakage 
that may result between endothelial cells proliferation during infection will be 
investigated via IVM mediated quantification of leakage of injected 1% FITC-dextran 
solution. However, while FITC-dextran perfusion occurs through the lymph node 
arteriole following inter-cardiac perfusion, the large fat pad surrounding the LN is auto-
fluorescent (Figure 21). This means that studies using the proposed dye leakage 
technique would subsequently require either complete removal of the fat or use of a 
different lymph node that is not obscured by adipocytes. 
Once the question of EC proliferation is addressed, understanding reversion to pre-
infection size becomes the next step in investigating arteriole remodeling further. 
Interestingly, of all the studies considered above that noted endothelial cell proliferation 
within the lymph node, with return to baseline levels, none proposed a mechanism of 
reversion. If LN arteriole remodeling docs in fact require EC proliferation, a proposed 
mechanism of return to baseline is through rapid apoptosis, which could be easily be 
explored through a TUNEL assay or screening for biomarkcrs of apoptosis. 
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Notably other factors than the mechanism of means by which arteriole remodeling 
is achieved and resolved should be addressed in order to understand the full vascular 
profile of lymph node arteriole remodeling. For example, while vessel size increases, do 
other aspects change within the vessel? Characteristics that should be considered due to 
their effect on flow within the vessel, and therefore supply to the LN, include blood 
pressure flow rate, and blood viscosity as this would affect shear stress within the vessel 
and would add to understanding the possible mechanism acting on the vessel itself or the 
potential impact of arteriole remodeling or HEV expression of adhesion molecules. The 
vascular profile would also be more comprehensive with a more complete of 
understanding of where and when LN arteriole remodeling can be observed and could be 
addressed looking at alternative pathogens, diseases and sites. In fact, preliminary 
observations made in the lab indicate that arteriole expansion is observed with vesicular 
stomatitis virus (VSV), and the use of alternative IVM preparations, such as those for the 
popliteal and cranial LNs, in order to investigate the arteriole remodeling in alternate sites 
is a viable option. 
Finally, future directions should come to focus on the mechanism driving arteriole 
remodeling. Based on studies of generalized LN vascular growth that implicated VEGF, a 
future hypothesis to be explored is that VEGF is the key factor in mediating rapid and 
robust vascular growth of the LN arteriole and that CD4" T cells are required for VEGF 
driven vascular growth. In support of this hypothesis, the timeline of arteriole remodeling 
corresponds to VEGF levels within stimulated lymph nodes; VEGF levels increase 
significantly by day one after infection and increase continuously until at least day five 
following OVA/CFA treatment or transfer of stimulated DCs and correspond to DC 
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numbers within the LN (Webster et ai, 2006). However, further study is required to test 
this hypothesis and would involve studies confirming the requirement of VEGF for LN 
arteriole remodeling, although a number of studies clearly supporting a role of VEGF in 
LN vascular growth (Chyou et al., 2008, Webster et ai, 2006, Shrcstha et ai, 2010). One 
notable approach to exploring the requirement for VEGF could utilize mice treated with 
anti-VEGF antibody, as this was a successful approach to confinning the role of VEGF in 
ECs proliferation in reactive LNs (Webster et ai, 2006). 
The role of CD4+ tells would also benefit from future experiments, particularly in 
the contcxt of aged mice as studies of LN T cell numbers and the ability to reconstitute 
the capacity of the LN arteriole to remodel have yet to be completed. This could be 
accomplished using FACS analysis of LNs from aged mice as well as reconstitution 
experiments in which CD4f T cells from adult mice will be transferred into an aged 
system. Alternatively, comparison of CD4"" mice given adult or old CD4f T cells may be 
a better option as it would eliminate the other factors within the aged mice that may be 
effecting remodeling and allow a clearer conclusion regarding whether low CD41 T cell 
levels are what is causing a the absence of arteriole remodeling during infection. If such 
experiments showed a marked decrease in CD4f T cells in the draining LN and the 
reinstatement of the ability to remodel, this would suggests that if it were possible to 
induce arteriole remodeling in an aged model, the quality of immune response during 
infection would improve given the link between LN enlargement and vascular expansion 
and CTL responses (Kumamoto et al., 2011). 
Finally, the role of NOS is an important future consideration. In order to delineate 
whether VEGF and eNOS expression is similar in the LN and the arteriole, 
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immunohistochcmistry of arterioles and LNs fixed and isolated at multiple time points 
p.i. with Tk"HSV-2 in both wild-type (C57 BL/6) and mice genetically deficient in eNOS 
would be effective. Furthermore, based on previous studies showing that both high levels 
and ablation of NO expression in blood vessels inhibits CD4f T cell rolling and 
subsequent migration, in conjuction with the blunted levels of NO observed in the LN 
arteriole three and five days p.i., and decreased LN hypertrophy in eNOS deficient mice, 
suggests that ablation of eNOS decreases cell trafficking into the LN, thereby leading to 
deficient numbers of CD4f T cells in the dLN and inhibition of arteriole remodeling 
(Kubcs, 1991, Martinclli et a/., 2009). Additionally, decrease of NO levels three and five 
days p.i., may function to lower NO production to optimal levels for CD4 cell trafficking 
into the LN. Therefore, to investigate the rate of trafficking of CD4+ T cells into the dLN 
in both eNOS" "and C57 BL/6 mice throughout the course of infection with specific 
attention to changes in trafficking rate between three and five days p.i., cell trafficking 
could be determined through FACS analysis of cell populations in harvested inguinal 
lymph nodes in WT and eNOS "mice. To address the possibility that CD4* T cells in 
eNOS " may potentially be intrinsically defective in homing capability, naive WT CD4* 
T cells (isolated using magnetic separation) could be labeled with CSFE and transferred 
i.v. into eNOS"" mice prior to infection with subsequent FACS analysis to evaluate 
accumulation in the LN (Soderberg et al., 2005). 
Notably, future experiments designed to determine the mechanism of blunted 
response to NOS inhibition are more difficult as none of the investigated components that 
drive arteriole expansion regulate this transient decrease in response. However, one 
hypothesis that was explored was that the decrease in NO was mediated through 
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decreased NOS activity, potentially through the binding by cavcolin-1. Unfortunately, 
caveolin-1 deficient mice were found to be highly sensitive to anesthetic protocol utilized 
and have unstable vascular diameters during IVM thereby indicating that this hypothesis 
will have to be explored by alternative means in the future. 
Despite this difficulty, the above considered future directions form a solid basis 
from which multiple, original projects can stem. Generally, these projects, would best be 
focused on further characterizing the nature of LN arteriole remodeling including 
considering EC proliferation and return of the arteriole to baseline, further elucidating the 
mcchanism driving arteriole remodeling and the subsequent impact on immune response, 
and exploring the mechanism governing transient NO levels during infection. The 
diversity and potential impact of these future directions are notable and are based on the 
findings presented in this study, which was the first to consider LN arteriole remodeling 
in-depth. Such consideration resulted in a number of novel outcomes including the 
characterization of magnitude, kinctics, and nature of arteriole remodeling, generation of 
a working hypothesis of the mcchanism governing arteriole remodeling, and elucidation 
of previously unknown links between LN arteriole remodeling and cellular trafficking, 
CTL function, and NO regulation, and as such, represent a important step forward in 
understanding LN physiology and vascularity, arteriole remodeling, and interaction 
between the microvasculature and immune response. 
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Figure 21: FITC-Dextran Perfusion Through the Inguinal Lymph Node Feed 
Arteriole. Inguinal lymph node arteriole (white arrow) and venule (red 
arrow) following perfusion with lOOul of 1% FITC-dextran in sterile lx PBS 
given intra-cardiac and allowed to circulate for ten minutes prior to imaging. 
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